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A Drosophila model of CYFIP1
haploinsufficiency, a genetic variant
linked to schizophrenia and autism,
reveals that increased mitochondrial
activity and membrane potential reduces
GABA availability and plays a causal role
in mediating social behavioral
abnormalities.
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Social impairment is frequently associated with
mitochondrial dysfunction and altered neurotrans-
mission. Although mitochondrial function is crucial
for brain homeostasis, it remains unknown whether
mitochondrial disruption contributes to social
behavioral deficits. Here, we show that Drosophila
mutants in the homolog of the human CYFIP1, a
gene linked to autism and schizophrenia, exhibit
mitochondrial hyperactivity and altered group
behavior. We identify the regulation of GABA avail-
ability by mitochondrial activity as a biologically
relevant mechanism and demonstrate its contribu-
tion to social behavior. Specifically, increased
mitochondrial activity causes gamma aminobutyric
acid (GABA) sequestration in the mitochondria,
reducing GABAergic signaling and resulting in so-
cial deficits. Pharmacological and genetic manipu-
lation of mitochondrial activity or GABA signaling
corrects the observed abnormalities. We identify
Aralar as the mitochondrial transporter that se-
questers GABA upon increased mitochondrial ac-
tivity. This study increases our understanding of
how mitochondria modulate neuronal homeostasis
and social behavior under physiopathological
conditions.1178 Cell 180, 1178–1197, March 19, 2020 ª 2020 Elsevier Inc.INTRODUCTION
Human brain, which account for just 2% of body weight, uses
20% of all mitochondrial energy (Castro et al., 2018; Mer-
genthaler et al., 2013). To fulfill these energy requirements, mito-
chondria supply neurons with energy by generating metabolites
via the tricarboxylic acid (TCA) cycle and ATP through oxidative
phosphorylation (OXPHOS) (Hollis et al., 2017; Vos et al., 2010).
Neurons rely on mitochondrial function for a variety of pro-
cesses, including neurogenesis, synaptic plasticity, and neuro-
transmission (Kann and Kovács, 2007; Khacho and Slack,
2018; Li et al., 2004; Marland et al., 2016; Raefsky and Mattson,
2017; Schwarz, 2013; Vos et al., 2010; Yang et al., 2012). During
synapse formation, the bi-directional flux of pre-synaptic
mitochondria is increased (Badal et al., 2019). Furthermore,
mitochondria regulate calcium buffering, controlling release of
neurotransmitters from neurons and ensuring proper synaptic
functioning (Williams et al., 2013) during development and in
the adult brain (Khacho and Slack, 2018; Picard, 2015; Son
and Han, 2018).
Converging lines of evidence support a role of mitochondria in
brain dysfunctions such as autism spectrum disorder (ASD),
schizophrenia (SCZ), and other disabilities featuring synaptic
dysfunctions (Castora, 2019; De Rubeis et al., 2014; Gandal
et al., 2018; Garcı́a-Cazorla et al., 2018; Hollis et al., 2017).
Mitochondrial dysfunction has been observed in ASD with a
prevalence of approximately 5%–8% (Ghanizadeh et al., 2013;
Griffiths and Levy, 2017; Legido et al., 2013; Patowary et al.,
2017; Rossignol and Frye, 2012; Toker and Agam, 2015; Valenti
et al., 2014) and in SCZ (Akarsu et al., 2014; Taurines et al., 2010).
Respiratory complex activity deficiencies as well as aberrant
overactivity have been observed in ASD children (Frye and Na-
viaux, 2011; Goldenthal et al., 2015) and patients with SCZ. A
positive correlation between mitochondrial complex I and III
mRNA levels has also been reported in SCZ (Akarsu et al.,
2014; Taurines et al., 2010) and in individuals with psychotic
symptomatology (Bergman and Ben-Shachar, 2016), but other
studies have shown the opposite; namely, impaired mitochon-
drial network dynamics associated with reduced cellular respira-
tion and complex I abnormalities in SCZ (Rosenfeld et al., 2011).
Furthermore, clinical studies have noted metabolic distur-
bances, including mitochondrial dysfunction at the levels of
mtDNA, activity, atypical redox metabolism, and differences in
metabolites in patients with ASD and SCZ (Hollis et al., 2017;
Konradi and Öngür, 2017; Patowary et al., 2017). Mitochondrial
genes have been reported to be differentially expressed in the
cerebral cortex of ASD patients and strongly correlated with
genes associated with synaptic transmission (Schwede et al.,
2018), and in SCZ, disruptions in mitochondria have been found
in different brain regions, cell types, and subcellular locations
(Konradi and Öngür, 2017). Recently, a human whole-genome
methylation study revealed that two crucial biological processes,
mitochondrial metabolism and protein ubiquitination, are associ-
ated with ASD brains (Stathopoulos et al., 2018). In agreement, a
genome-wide association study (GWAS) showed significant
enrichment for ASD- and SCZ-associated common variants in
genes that regulate synapse and mitochondrial homeostasis
(Gandal et al., 2018). Although these studies suggest a potential
association between energetic balance, synaptic transmission,
and psychiatric disease, the functional significance of mitochon-
drial disturbances for neurological disease and the mechanistic
links between these processes remain unclear.
Copy number variations (CNVs) and single-nucleotide variants
(SNVs) in the cytoplasmic FMR1-interacting protein 1 (CYFIP1)
gene have been associated with SCZ and ASD (Leblond et al.,
2012; Stefansson et al., 2014; Tam et al., 2010; Vanlerberghe
et al., 2015; Wang et al., 2015; Zhao et al., 2013). Furthermore,
genomic instability at the 15q11.2 BP1-BP2 locus, which en-
compasses four genes, including CYFIP1, has also recently
emerged as a recognized syndrome (Cafferkey et al., 2014;
Cox and Butler, 2015; De Wolf et al., 2013; Nevado et al.,
2014; Urraca et al., 2013; Williams et al., 2019; C Yuen et al.,
2017). Among the four implicated genes, converging evidence
suggests that CYFIP1 is a key factor mediating risk for the
BP1-2-deletion disorders (Das et al., 2015; Nebel et al., 2016;
Vanlerberghe et al., 2015; Wang et al., 2015; Woo et al., 2016;
Yoon et al., 2014). CYFIP1 has a dual role in the brain, regulating
local protein synthesis by binding eIF4E and controlling actin re-
modeling as part of the hetero-pentameric wave regulatory com-
plex (WRC) (Anitei et al., 2010; Chen et al., 2010b; De Rubeis
et al., 2013; Di Marino et al., 2015; Eden et al., 2002; Genheden
et al., 2015; Hsiao et al., 2016; Napoli et al., 2008; Oguro-Ando
et al., 2015; Panja et al., 2014; Pathania et al., 2014; Schenck
et al., 2003; Stradal and Scita, 2006). Moreover, recent studies
demonstrated that CYFIP1 haploinsufficiency in humans, ro-
dents, and flies confers domain-specific cognitive impairments
and behavioral deficits (Bachmann et al., 2019; Bozdagi et al.,2012; Domı́nguez-Iturza et al., 2019; Silva et al., 2019; Woo
et al., 2019). However, the molecular mechanisms linking
CYFIP1 deficiency with alterations in behavior and cognition
remain unknown.
Here we investigated the molecular mechanism underlying
social behaviors in Drosophila, demonstrating a mechanistic
link between alterations in mitochondrial metabolism, neuronal
communication, and social behavior. By using CYFIP haploin-
sufficient flies, we show that an increase in mitochondrial activ-
ity, energy metabolism, and membrane potential causes
abnormal gamma aminobutyric acid (GABA) signaling, leading
to deficits in social group interactions in flies. Furthermore,
we identify the solute carrier Aralar as the mitochondrial trans-
porter responsible for uptake of GABA into mitochondria, which
is activated by mitochondrial membrane polarization. We pro-
vide genetic, biochemical, pharmacological, and morphological
evidence that explains how dysregulation of mitochondrial ho-
meostasis regulates GABA signaling and the social component
of behavior.
RESULTS
Cyfip85.1/+ Flies Have Deficits in Social Behavior
CYFIP haploinsufficiency in humans and flies has been shown
recently to confer domain-specific cognitive impairments
(Woo et al., 2019). Because increasing evidence points toward
a role of CYFIP1 in ASD- and SCZ-like behaviors (Domı́nguez-
Iturza et al., 2019; Silva et al., 2019), and given the prevalence
of social deficits in these disorders, we investigated whether
CYFIP haploinsufficiency affects ASD-like behaviors by
comparing Cyfip85.1/+ (Schenck et al., 2003) and control flies
in well-established paradigms for social group behavior. First,
male flies were tested in a food competition assay (Anholt
and Mackay, 2012; Zwarts et al., 2011), where the index of ap-
proaches was used to obtain an average of the total number of
social events in a 2-min time frame. Cyfip85.1/+ male flies
showed a reduced number of social events relative to control
flies (Figure 1A; Video S1). This also holds true for female flies
(Figure S1A). Second, Cyfip85.1/+ flies were further investigated
by observing Drosophila courtship, a complex innate social
behavior in flies (Ejima and Griffith, 2007; Sokolowski, 2010).
Cyfip85.1/+ male flies showed a decreased courtship index to-
ward a control female (Figure 1B; Video S2). Third, we moni-
tored the grooming behavior of individual flies as described
previously (Tauber et al., 2011). Cyfip85.1/+ male flies showed
excess grooming behavior in comparison with control flies (Fig-
ure 1C; Video S3), suggesting an increase in repetitive
behavior. Moreover, we recorded the behavior of flies within
a social group, measuring the distance between two flies as so-
cial space (Simon et al., 2012). Cyfip85.1/+ flies, on average,
showed greater distances to the nearest neighbor fly compared
with control flies within a group (Figure 1D), further confirming
the social interaction impairment of Cyfip85.1/+ flies. In addition,
Cyfip85.1/+ flies stayed farther away from the wall of the open
field arena (Figure 1D), indicating disruption of their natural thig-
motactic behavior (attraction to the contact of the wall) (Besson
and Martin, 2005). Cyfip85.1/+ flies exhibit hyperactivity over



































































































































































Figure 1. Deficits in Social Behavior in Flies Harboring the CYFIP Haploinsufficiency
(A and B) Control (w1118),Cyfip85.1/+, TM3/+, andCyfip85.1/TM3 flies were analyzed for total number of social interactions in a competition for food assay ([A], n >
20 groups of 8 flies each) or in a courtship assay ([B], n > 20 flies).
(C) Grooming behavior. The percentage of time spent grooming was monitored over a period of 3 min in control and Cyfip85.1/+ flies. n = 10–12 individual flies for
each genotype.
(D) Social space behavior. Left: representative images of an open field assay. Red circles indicate flies staying close together. Middle: quantification of the
distance of each fly to its closest neighbor for control andCyfip85.1/+ flies. n = 8 groups of 30 flies for each genotype. Right:Cyfip85.1/+ flies keep a greater distance
from the wall of an open arena. n = 8 replicates of 30 flies for each genotype.
For all paradigms, data are shown with box-and-whisker plots, where the line inside the box indicates the median. ****p < 0.0001, ***p < 0.001, **p < 0.01, Mann-
Whitney test.in locomotion activity were observed during the daytime (Zeit-
geber time, ZT0–ZT6) (Figure S1C), the time frame when the so-
cial assays were performed. This indicates that hyperactivity
does not interfere with our social behavioral assays and that
the observed social deficits were not due to impaired motor
ability. Cyfip mutant flies (males and females) do not differ
from controls (Figures S1D and S1E) in negative geotaxis as
a measure of motor reflex (Sun et al., 2018), anxiety (Garcia
and Teets, 2019), or startle response (Zhang et al., 2002).
Finally, we used the Temporal and Regional Gene Expression
Targeting (TARGET) system to interrogate specific effects of
Cyfip knockdown by transgenic RNAi (upstream activation
sequence [UAS]-Cyfip-IR) expression in the adult animal
(McGuire et al., 2003). Pan-neuronal attenuation of Cyfip
mRNA levels in adult flies (Figure S1F) phenocopied the
decreased competition for food in Cyfip85.1/+ mutant animals
(Figure S1G). The decreased social score in Cyfip85.1/+ flies
was fully rescued by expression, in adulthood only, of a trans-
gene harboring the wild-type Cyfip (UAS-Cyfip-wild-type [WT]/
genetic rescue) (Figure S1G). These data provide evidence that
CYFIP is required for proper social behavior in adult flies.1180 Cell 180, 1178–1197, March 19, 2020Proteomics Analysis of Cyfip85.1/+ Mutant Flies Reveals
Deficits in Mitochondrial Pathways and Disease
Networks
To identify the molecular mechanism underlying the observed
behavioral dysfunctions in Cyfip85.1/+ flies, we performed tan-
demmass spectrometry in control andCyfip85.1/+mutant brains.
Analysis identified a total of 345 dysregulated proteins, of which
309 were present at greater abundance and 36 at lower abun-
dance in Cyfip85.1/+ flies compared with controls (Table S1).
The identified proteins corresponded to 361 fly genes and map-
ped with high confidence to 264 human orthologs (i.e., 73%). Fly
protein-protein interaction (PPI) and cluster networks were then
constructed bymining publicly available databases: FlyBase (At-
trill et al., 2016), BioGRID, IntAct, BIND, DIP (Salwinski et al.,
2004), and MINT (Salwinski et al., 2004) (Figure 2A). The stron-
gest signal recovered in these network-based analyses was for
the community of mitochondrial proteins (community 3, p =
2.4 3 106, permutated p < 1%). This mitochondrial signal was
likewise one of the top hits in the Gene Ontology analysis, iden-
tifying differentially expressed mitochondrial proteins (Figure 2B;
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energy metabolism, and mitochondrial electron transport as well
as neurotransmitter release-related processes (Figure 2C; Fig-
ure S2). Further, disease-related analyses identified a highly sig-
nificant overrepresentation of gene networks implicated in SCZ,
dementia, and syndromic epilepsy (Figure 2D).
Cyfip85.1/+ Flies Show Increased Brain Mitochondrion
Size and Respiration
Given that our proteomics analysis suggested a role ofmitochon-
dria and energy metabolism in Cyfip85.1/+ flies, we assessed
whether the mutant flies showed alterations in mitochondrial
respiration. Using high-resolution respirometry, we observed a
striking increase in mitochondrial respiratory capacity through
the respiratory chain in Cyfip85.1/+ brains (Figure 3A), both at
the level of coupled respiration through complexes I and II (com-
plex I [CI] andcomplex I+II [CI+II]) andat the level ofmaximal elec-
tron transfer (ET) capacity (CI+II ET) (Figure 3B). The respiration
differences appear to be driven mostly by CI and complex IV
(COX) (Figure 3B). In contrast, no alterationswere observed in ox-
ygen consumption in Cyfip85.1/+ fly bodies (Figure 3C), suggest-
ing that mitochondrial activity is specifically dysregulated in the
CNS. Labeling brains with tetramethylrhodamine ethyl ester
(TMRE), an established marker for mitochondrial membrane po-
tential (Perry et al., 2011), revealed increased signal intensity in
Cyfip85.1/+ brains, further suggesting that the flies exhibit
increased mitochondrial membrane potential (Figure 3D). This
finding was also confirmed by Rhodamine 123 staining (Fig-
ure S3A). No differences were observed in mitochondrial DNA
(mtDNA) copy number and mitochondrial protein levels between
Cyfip85.1/+ mutants and controls (Figure 3E; Figures S3B and
S3C). We used another widely usedmarker of mitochondrial pro-
teinmass, citrate synthase (CS) activity (Spinazzi et al., 2012). CS
activity in Cyfip85.1/+ mutants was not altered compared with
control brains (Figure S3D). Next, mitochondrial morphology
was analyzed by transmission electron microscopy (TEM) in fly
brains from both genotypes, and a remarkable difference was
observed in the mutant flies. Mitochondrion area and perimeter
were increased in Cyfip85.1/+ mutant flies versus controls (Fig-
ure 3F). The higher metabolic rate of Cyfip85.1/+ flies is not due
to higher food consumption because feeding during the daytime
(Figure S3E) and over 24 h (Figure S3F) were not altered. In
conclusion, these data reveal that the mitochondrial activity
and size are increased in Cyfip85.1/+ mutant flies.
Cyfip85.1/+ Flies Have an Excessive TCA/Krebs Cycle
The high enrichment of proteins relating to mitochondrial func-
tion (OXPHOS and TCA cycle) in the mass spectrometry datasetFigure 2. The CYFIP Haploinsufficiency Proteome Revealed Maladapti
(A) Clustering of the fly CYFIP PPI network. The modularity-based Potts and simu
genes are shown in red, cytoskeleton-related genes in navy blue, and synaptic ve
corrected for using a permutation study, for mitochondrion-, cytoskeleton-, and s
106, permutated p = < 1%; community 18, p = 0.0194816, permutated p = 0.92
(B and C) GO cellular component analysis (B) and GO biological functions ana
calculated using the topology-based elimination Fisher method.
(D) Disease enrichment values for the deregulated genes of Cyfip85.1/+ flies com
tation data. Enrichment values were calculated using the topology-based elimina
make use of the full Human Disease Ontology (HDO) ontology tree (6,331 terms)
1182 Cell 180, 1178–1197, March 19, 2020(Figure S2) and the demonstration of increased mitochondrial
respiration in the Cyfip85.1/+ fly brain prompted us to investigate
whether Cyfip85.1/+ flies have any changes in the TCA cycle
(tricarboxylic acid or Krebs cycle). First, TCA metabolites (Fig-
ure 4A) were determined by stable isotope dilution liquid chro-
matography-mass spectrometry (LC-MS) from Cyfip85.1/+
brains. Of the metabolites that are produced in the TCA cycle it-
self, isocitrate, a-ketoglutarate [a-KG]/2-oxoglutarate, and suc-
cinate levels are increased in Cyfip85.1/+ flies, indicating that
enzymatic activities in this section of the cycle are higher (Fig-
ure 4B). Of note, a-KG and isocitrate dehydrogenase generate
NADH, providing electron equivalents to CI, and succinate fuels
complex II, suggesting that upregulation of the TCA cycle is
responsible for the increased CI activity we observed in the
Cyfip85.1/+ brain (Figure 3B; Maguire et al., 2015). Examination
of the MS data further validated that the levels of NADH-produc-
ing enzymes, specifically the nicotinamide adenine dinucleotide
(NAD)-dependent isocitrate dehydrogenase (IDH) (Yoon et al.,
2017) and a-KG hydroxylase, are indeed upregulated, as indi-
cated by the Gene Ontology (GO) analysis (Table S2). NAD-
IDH activity increased 3-fold in Cyfip85.1/+ brains compared
with controls (Figure 4C), and the activity of a-KG-dependent hy-
droxylase was also significantly increased in Cyfip85.1/+ brains
(Figure 4D). Interestingly, the total levels of oxidized and reduced
forms of NAD (NADt; NAD+ and NADH) were not altered between
Cyfip85.1/+ and controls in isolated mitochondria (Figure 4E);
however, the reduced form (NADH) had a significantly higher
level (Figure 4F). Tracing of 13C-labeled glucose shows a drastic
increase in isotope-labeled succinate in Cyfip85.1/+ flies,
whereas incorporation of the 13C label into to malate and cit-
rate/isocitrate was not changed (Figure 4G). This confirms that
the biochemical reactions between citrate/isocitrate and succi-
nate (i.e., IDH and aKG) are overactive and shows that TCA cycle
overactivity is fueled by glycolysis. Further analysis of the amino
acid composition using stable isotope tracing as well as hydro-
philic interaction LC coupled to tandem MS (HILIC-MS/MS) re-
vealed higher levels of amino acids related to the TCA cycle in
Cyfip85.1/+ brains (Figures S4A and S4B). These findings confirm
that the Cyfip85.1/+ brain shows increased TCA cycle and CI
activity.
The Deficit in Social Behavior in Cyfip85.1/+ Flies Is
Energy Dependent
Given that Cyfip85.1/+ flies have altered social behaviors and
increasedmitochondrial respiration, we testedwhether the alter-
ations in mitochondrial function were causally involved in medi-
ating the behaviors seen in the Cyfip85.1/+ flies. We normalizedve Mitochondrial Function and Energy Production
lated annealing algorithms available in R were used. GOmitochondrion-related
sicle-related genes in orange. Enriched clusters, using the hypergeometric test
ynaptic vesicle-related GO terms are also highlighted. Community 3, p = 2.43
375%.
lysis (C) of Cyfip85.1/+ flies compared with controls. Enrichment values were
pared with controls using combined OMIM/geneRIF/Ensembl variation anno-
tion Fisher method; n = number of disease genes found in the dataset; p values
.
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Figure 3. Increased Brain Mitochondrial Activity, Membrane Potential, and Size in CYFIP-Haploinsufficient Flies
(A) A representative graph of the high-resolution respirometry experiment in control and Cyfip85.1/+ fly brains. The blue line represents the oxygen concentration
and the red line the oxygen consumption flux.
(B) Quantification of the oxygen consumption normalized per unit (1 unit corresponds to 1 brain) of control and Cyfip85.1/+ flies. nR 6 independent experiments
per genotype (each with 10 fly brains), mean ± SEM. **p < 0.01, multiple t test, corrected for multiple comparisons using the Sidak-Bonferroni method.
(C) Same as in (B) ofCyfip85.1/+ fly bodies (no heads). Normalization by protein concentration (milligrams). nR 7 independent experiments per genotype, mean ±
SEM. ns, not significant, multiple t test, corrected for multiple comparisons using the Sidak-Bonferroni method.
(legend continued on next page)
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energy production by reducing IDH activity to partially inhibit the
TCA cycle. Using idh3a mutant flies, which have decreased IDH
activity and reduced a-KG levels (Ugur et al., 2017), we found
that social behavior in the food competition assay was reduced
in idh3a/+ flies and that idh3a/+;Cyfip85.1/+ flies behaved as the
controls (Figure 5A). Further, pharmacological inhibition of IDH
activity using ML309, a selective inhibitor of IDH that effectively
lowers the production of a-KG levels (Davis et al., 2014), also
ameliorated the abnormal social behavior inCyfip85.1/+ flies (Fig-
ure 5B). Interestingly, idh3a /+ single mutation or overexpression
of IDH in the fly brain (Figure 5C) showed a reduction in social
behavior similar to Cyfip85.1/+ flies, suggesting that too much
and too little energy production lead to a social behavioral
defect. Importantly, the ML309 compound also restored the
increased mitochondrial activity in Cyfip85.1/+ flies (Figure 5D).
These results demonstrate a surprising association of social
behavior with the TCA cycle and highlight the importance of
the IDH enzyme as a potential therapeutic target.
We next designed an experiment to test whether dampening
mitochondrial activity and mitochondrial membrane potential
can normalize social behavior. Control and Cyfip85.1/+ flies
were fed rotenone (an inhibitor of CI) for 4 days at a concentration
approximately 500 times lower than that used to model Parkin-
son’ disease in flies. Although this treatment had no effect on
the behavior of control flies (Figure S4C), we found that it amelio-
rates social deficits inCyfip85.1/+mutants (Figure 5E) after 4 days
of feeding. The effect of rotenone treatment was reversible (Fig-
ure S4D). Of note, the same treatment did not restore the hyper-
activity of Cyfip85.1/+ mutants (Figure S4E), suggesting that the
mitochondrial phenotype is specific to social behavior. More-
over, reducing CI activity by crossing Cyfip85.1/+ flies to flies
with a genetic reduction in CI activity (Pink1B9/+ mutants; Morais
et al., 2009) also rescued social behavior to levels that were
indistinguishable from controls (Figure 5F). As for the Idh3a
mutant, Pink1B9/+ flies exhibited social deficits similar to those
seen in Cyfip85.1/+ mutants. Finally, western blot analysis re-
vealed that Cyfip85.1/+ mutants harbored increased levels of
the mitochondrial CI subunit NDUFS3 (Figure S3B), consistent
with the MS data. Assessments of ndufs3/+ mutant flies,
harboring a mutation affecting mitochondrial CI, also uncovered
abnormal social behavior in these flies, whereas the double
ndufs3/+;Cyfip85.1/+mutants were normal with regard to number
of social interactions (Figure 5F). Combined, these results point
to a causal role of mitochondria and energy metabolism in the
regulation of a complex social behavior.
Reduction of CYFIP in a Subset of GABAergic Neurons
Recapitulates the Social Interaction Deficits
Excitation/inhibition balance in microcircuitries plays an essen-
tial role in the pathophysiology of psychiatric disorders with(D) Measurement of the mitochondrial membrane potential. Left: representative Z
lobe (AL) area was quantified (highlighted with a red circle). Right: quantification o
TMRE fluorescence intensity from the AL area. n = 15–16 brains per genotype, m
(E) Mitochondrial DNA copy number measured in control and Cyfip85.1/+ fly brain
Whitney test.
(F) Left: representative electron microscopy (EM) images of mitochondria from
perimeter and area. n = 160–165 mitochondria per genotype, mean ± SEM. ****p
1184 Cell 180, 1178–1197, March 19, 2020shared social deficits (Benke and Möhler, 2018; Boccuto et al.,
2013; Brambilla et al., 2003; Cellot and Cherubini, 2014; Coghlan
et al., 2012; Edden et al., 2012; Friedman et al., 2003; Kuo and
Liu, 2019; Mukherjee et al., 2019; Robinson and Gradinaru,
2018; Zoghbi and Bear, 2012). In both in ASD and SCZ, there
is differential expression of mitochondrial genes in different brain
regions, cell types, and subcellular locations (Konradi and
Öngür, 2017). Therefore, to determine whether a specific cell
type is responsible for the deficit in Cyfip85.1/+ social behavior,
we knocked down CYFIP individually in both major excitatory
(cholinergic) and inhibitory (GABAergic) neurons (Hsu and Bhan-
dawat, 2016; Kolodziejczyk et al., 2008; Lee et al., 2003),
neuronal clusters important for social behavior in the fly brain
(Koganezawa et al., 2016; Yuan et al., 2014). No effect on social
behavior was observed when CYFIP levels were reduced in
cholinergic neurons (Figure 6A). However, depletion of CYFIP
in GABAergic neurons recapitulated the feeding-dependent so-
cialization defect seen in Cyfip85.1/+ flies (Figure 6B), and this
could be rescued by genetic reintroduction of Cyfip. Attenuation
of Cyfip mRNA levels specifically in GABAergic neurons was
confirmed (Figure S5A).
The Drosophila brain contains around a thousand well-map-
ped GABAergic neurons responsible for distinct behaviors (Fig-
ure S5B). This allowed us to further investigate possible defects
in the GABAergic system by assessing subsets of GABAergic
neurons sensitive to Cyfip dosage. To do so, the GAL4 system
was used to deplete CYFIP individually in three distinct
GABAergic interneuron subtypes: in anterior paired lateral
(APL) neurons (a single GABAergic neuron per brain hemisphere
that innervates the ipsilateral mushroom bodies [MBs] through
broad projections; Liu and Davis, 2009; Masuda-Nakagawa
et al., 2014; Wu et al., 2011); in antennal lobe local interneurons
(LNs), whose processes are restricted to a local region; and in
dorsal paired medial (DPM) neurons, which project to the MBs
to stabilize memories. Reducing CYFIP levels in APL neurons
or LNs recapitulated the behavioral deficits observed with pan-
neuronal or pan-GABAergic knockdown, whereas no effect
was observed for the DPM neurons (Figure 6C).
A Reduction in CYFIP Causes GABA to Accumulate in
Mitochondria
Given the sensitivity of GABAergic cells to Cyfip dosage, we
investigated vesicular GABA levels in Cyfip85.1/+ flies. Immuno-
histochemistry experiments (Homberg and Müller, 2016; Tochi-
tani and Kondo, 2013) ofCyfip85.1/+whole-mount brains showed
reduced vesicular GABA levels (Figure 6D). To address whether
such a reduction was due to a pre- or post-synaptic phenotype,
we monitored synaptic transmission in GABAergic neurons.
By expressing UAS-synaptopHluorin (Ng et al., 2002) in
GABAergic neurons (Figure 6E), we uncovered a surprisingprojections of confocal images of fly brains stained with TMRE. The antennal
f TMRE staining from control and Cyfip85.1/+ flies. Shown is the fold change in
ean ± SEM, **p < 0.01, Mann-Whitney test.
s relative to nuclear DNA. n = 4 (groups of 10 fly brains), mean ± SEM, Mann-
control and Cyfip85.1/+ fly brains. Right: quantification of the mitochondrion
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Figure 4. Altered TCA Cycle and Metabolism in CYFIP-Haploinsufficient Flies
(A) Simplified representation of the TCA cycle and metabolites measured in fly brains.
(B) Quantification of metabolites from the TCA cycle in Cyfip85.1/+ brains normalized to the control. n = 5 (groups of 10 fly brains), mean ± SEM. ***p < 0.001,
**p < 0.01, *p < 0.05, Kruskal-Wallis test, Dunn’s multiple comparison test.
(C) Enzymatic activity of NAD-IDH dependent from Cyfip85.1/+ brains normalized to the control. n = 3–4 (group of 10 fly brains), mean ± SEM. **p < 0.01, Mann-
Whitney test.
(D) The same as in (C) for aKG enzymatic activity. n = 3–4 (groups of 10 fly brains), mean ± SEM. *p < 0.05, Mann-Whitney test.
(legend continued on next page)
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increase in synaptic release in GABAergic neurons of Cyfip85.1/+
flies in comparisonwith control flies (Figure 6F). Using in vivoCa2+
imaging in GABAergic neurons (Pech et al., 2015), Cyfip85.1/+
flies showed no changes in presynaptic Ca2+ responses (Fig-
ure S5C). Furthermore, the number of GABAergic neurons, as
probed by glutamic acid decarboxylase 1 (GAD1) staining, re-
vealed no difference in the brains of Cyfip85.1/+ and control flies
(Figure S5D).GAD1mRNA and protein levels also did not change
(Figures S5E and S5F). These findings prompted us to measure
glutamate levels, the metabolic precursor of GABA, by immuno-
histochemistry (data not shown) and HILIC-MS/MS (Figure S6A).
No differences in glutamate levels were observed between
Cyfip85.1/+ and control flies. Interestingly, the total concentration
of GABA in Cyfip85.1/+ mutants was not altered compared with
controls, as seen by HILIC-MS/MS (Figure 6G). Combined, these
results suggest that the entire pool of synthetized GABA (meta-
bolic, intracellular, and extracellular) is not altered.
The increased activity of the Krebs/TCA cycle in Cyfip85.1/+
flies lead us to hypothesize that GABA might be driven into the
mitochondria, generating NADH and succinate to the Krebs/
TCA cycle (Bönnighausen et al., 2015; Carillo, 2018; Maguire
et al., 2015; Michaeli et al., 2011). We therefore measured
GABA levels by ELISA following fractionation to enrich mito-
chondria and synaptic vesicles (Depner et al., 2014). Interest-
ingly, GABA concentration in the mitochondrial fraction of Cy-
fip85.1/+ mutants was markedly higher compared with controls,
reduced in the synaptic vesicles, and, as also observed by
HILIC-MS/MS, unchanged in the total fraction (Figure 6H). The
purity and enrichment of the mitochondrial preparation was
confirmed by western blot with the mitochondrial marker
ATP5B and the synaptic marker BRP (Figure S6B). Taken
together, these data are consistent with the idea that a reduction
in CYFIP causes redistribution of GABA from a vesicular/synap-
tic to a mitochondrial compartment, supporting the elevated
mitochondrial activity in Cyfip85.1/+ flies and leading to subse-
quent alterations in social behavior.
GABA Augmentation Fully Normalizes Behavioral
Abnormalities in Cyfip85.1/+ Flies
Given that Cyfip85.1/+ flies show a redistribution of GABA from a
synaptic to a mitochondrial compartment and that loss of CYFIP
in GABAergic interneurons is sufficient to cause behavioral def-
icits, we next investigated whether sequestration of GABA is
causally involved in CYFIP-related behavioral abnormalities. To
do so, we augmented GABA levels in Cyfip85.1/+ flies in three
distinct ways: by feeding flies GABA, DL-2,4-diaminobutyric
acid (DABA; a GABA transaminase uptake inhibitor), or the anti-
convulsant valproic acid (VPA; induces GABA release) (Chateau-
vieux et al., 2010; Coghlan et al., 2012; Reynolds et al., 2007).
Feeding Cyfip85.1/+ flies GABA for 5 days (Figure 6I) or DABA(E and F) Relative levels of NAD total (E) and NADH (F) of fly brains from control an
Whitney test.
(G) Contribution of [U-13C6]glucose to TCA cycle metabolites in Drosophila brain
topolog profile (i.e., the mass isotopolog distribution [MID]) of labeled metabolites
glucose leads to M+3 pyruvate. Decarboxylation of pyruvate makes M+2 acetyl-c
All TCA cycle intermediates downstreamof citrate will have amass ofM+2. Values
**p < 0.01, *p < 0.05, Sidak’s multiple comparisons test.
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deficit. Interestingly, feeding flies GABA also rescued behavioral
deficits in adult flies with pan-neuronal abrogation of Cyfip (Fig-
ure S6E). Similarly, pan-neuronal abrogation in adult flies of the
enzyme glutamic acid decarboxylase (GAD1) for 2 days led to
a reduced number of social events (Figure S6F). Separate exper-
iments in adult control flies showed that a high-GABA diet actu-
ally decreased social interaction (Figure S6G). Furthermore,
feeding flies diazepam (valium), a positive allosteric modulator
of the GABAAR receptor, was also able to restore the social def-
icits of Cyfip85.1/+ flies (Figure S6H). These data show that
augmentation of GABAergic signaling in adults is sufficient to
ameliorate the behavioral deficits in flies resulting from reduced
Cyfip dosage. Finally, underscoring the centrality of GABAergic
signaling to this process, we demonstrate that administration
of GABA, DABA, or VPA to GABAergic-specific CYFIP-depleted
flies also restores social interactions (Figure S6I). The effect of
GABA administration lasted 2 days after treatment (Figure S6J).
The Transporter Aralar Drives the Excessive
Mitochondrial Accumulation of GABA in Cyfip85.1/+ Flies
Our findings suggest that reduced available GABA causes social
deficits in Cyfip85.1/+ flies and that the reduction in vesicular
GABA is due to GABA being transported into mitochondria,
where it is catabolized into other intermediates through the
GABA shunt and TCA cycle. We therefore set out to determine
how GABA is being shunted into mitochondria.
Mitochondrial GABA transporters in eukaryotes have re-
mained mostly uncharacterized (Bönnighausen et al., 2015).
From GO:0005741 term, mitochondrial outer membrane (Table
S3), we identified 35 candidate transporters in the fly and per-
formed a genetic screen to test their effects in Cyfip85.1/+ flies.
Flies with mutations in the 35 putative GABA transporters were
individually crossed with Cyfip85.1/+ flies and tested in the food
competition social interaction paradigm. Of the 35 putative
GABA transporters tested, only the AralarMI07552 mutant showed
a significant effect, completely rescuing the behavioral deficits of
Cyfip85.1/+ flies (Figures 7A and 7B). Crossing the Cyfip85.1 fly
with the AralarMI0755 mutant also ameliorated the Cyfip85.1/+
grooming and social space behavior deficits (Figures 7C and
7D) but not their hyperactivity (Figure S7A), further confirming
thatmitochondrial dysregulation and Aralar have a specific effect
on social behavior.AralarMI07552/+mutant flies exhibit decreased
competition for food (Figure 7B), decreased grooming (Fig-
ure 7C), and hyperactivity (Figure S7A), similar toCyfip85.1/+ flies.
Aralar has so far been described for its function as a carrier
exchanging a glutamate and a proton (H+) from the cytoplasm
for an aspartate in mitochondria. This transport stoichiometry in-
dicates that the proton gradient drives the transport (Palmieri,
2013). To assess whether GABA localization was affected byd Cyfip85.1/+ flies. n = 4 (groups of 10 fly brains), mean ± SEM. *p < 0.05, Mann-
tissue after 6 h of feeding with [13C]glucose. The x axis denotes the 13C iso-
after incorporation of the [13C] glucose skeleton. The catabolism of 13C-labeled
oenzyme A (CoA) in mitochondria, which is then incorporated into M+2 citrate.

















































































































































































































































































Figure 5. TCA Cycle and Mitochondrial CI
Inhibition Restores Social Deficits in Cyfip
Mutant Flies
(A) Social behavior of Cyfip85.1/+ flies upon genetic
reduction of idh3a; more than 10 groups of 8 flies
for each genotype were analyzed; ***p < 0.001,
**p < 0.01, Kruskal-Wallis test, Dunn’s multiple
comparison test.
(B andC) Social behavior upon treatment with 5 mM
of ML309 for 1 day or 3 days of Cyfip85.1/+ flies (B)
and upon pan-neuronal IDH overexpression (29C)
in adults (C). n > 10 groups of 8 flies for each ge-
notype; **p < 0.01, ****p < 0.0001, ***p < 0.001,
Kruskal-Wallis test, Dunn’s multiple comparison
test.
(D) Quantification of oxygen consumption normal-
ized per unit upon treatment with 5 mM of ML309
for 3 days of control and Cyfip85.1/+ flies. n R 4
independent experiments per genotype (each with
10 fly brains), mean ± SEM. *p < 0.05, multiple
t test, corrected for multiple comparisons using the
Sidak-Bonferroni method.
(E and F) Competition for food upon feeding with
10 mM rotenone for 1 day, 2 days, and 4 days in
Cyfip85.1/+ flies (E) and upon genetic reduction of
pink1 or ndufs3 (F). More than 10 groups of 8 flies
for each genotype were analyzed; ****p < 0.0001,
Kruskal-Wallis test, Dunn’s multiple compari-
son test.the mutation in Aralar, GABA levels were evaluated by ELISA
upon fractionation of mitochondrial and cytosolic components.
Although cytoplasmic GABA levels were increased in
AralarMI07552/+ mutant brains, the levels and sequestration pro-
file of GABA across the cytoplasm and mitochondria in
AralarMI07552/Cyfip85.1 double mutants were indistinguishablefrom controls (Figure 7E). The combined
genetic and localization data strongly
suggest that Aralar is a GABA transporter.
In support of our model, inhibition of
Aralar by pyridoxal 50-phosphate (PLP)
(Amoedo et al., 2016) ameliorated the
competition for food of the Cyfip85.1/+
flies (Figure S7B).
To address how a reduced dose ofCyfip
could change the activity of Aralar, we
examined whether CYFIP controls Aralar
expression. Neither the Aralar mRNA level
(Figure S7C) nor its efficiency of translation
or distributionof themRNAonapolysome/
messenger ribonucleoprotein (mRNP)
gradient changed (FigureS7D), suggesting
that the regulation occurs at the level of
Aralar activity.
As a final test of our hypothesis, we
aimed to increase the proton gradient
across the mitochondrial membrane,
which increases Aralar activity, and
monitor social behavior in a control fly.
Flies were treated with a sublethal doseof oligomycin to reduce complex V activity (Spinazzi et al.,
2019), reducing the proton flux and increasing mitochondrial
membrane potential (Figure 7F). Notably, under these condi-
tions, the competition for food of control flies was decreased
(Figure 7G) together with the level of available GABA in the
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These data further support our previous observations that ho-
meostasis of mitochondria GABA levels plays an important role
in driving social behavior.
DISCUSSION
Using aDrosophilamodel ofCyfip1 haploinsufficiency, a hotspot
genetic variant increasing the risk for SCZ and a candidate risk
factor for ASD, we revealed that increased mitochondrial activity
andmembrane potential (Figure 3) reduceGABA availability (Fig-
ure 6) and play a causal role in mediating social behavioral ab-
normalities (Figure 1).
Contribution of GABA Transmission to Brain
Dysfunctions
It has been suggested that neurodevelopmental disorders may
result from an imbalance between the excitatory glutamatergic
and the inhibitory GABAergic pathways (Ben-Ari, 2017; Benke
and Möhler, 2018; Braat and Kooy, 2015; Cellot and Cherubini,
2014). Changes in inhibitory activity that lead to altered excit-
atory/inhibitory (E/I) balance in specific brain areas have been re-
ported in patients with ASD, SCZ, and epilepsy (Foss-Feig et al.,
2017; Sohal and Rubenstein, 2019; Yizhar et al., 2011). Mecha-
nistic studies in mice using optogenetic manipulations in medial
prefrontal cortex (mPFC) have demonstrated that increasing the
E/I ratio leads to social deficits, whereas restoration of E/I
balance by increasing inhibition in specific GABAergic neurons
(parvalbumin positive, PV+) rescues the observed social deficits
(Selimbeyoglu et al., 2017; Sohal and Rubenstein, 2019; Yizhar
et al., 2011). In addition, treatment with benzodiazepine, which
enhances GABAAR receptor activity, ameliorates social behav-
ioral deficits in mouse models of epilepsy and ASD (Han et al.,
2012, 2014; Sohal and Rubenstein, 2019), consistent with our
data in flies (Figure S6). Further, developmental Gabrb3 deletion
in mouse somatosensory neurons leads to tactile sensitivity and
reduced sociability through loss of GABAAR receptor-mediated
presynaptic inhibition, pointing out the importance of somato-
sensory dysfunction in ASDs (Orefice et al., 2016). It is notable
that CYFIP1 is enriched at inhibitory synapses and that loss of
CYFIP1 in rodents increases the E/I ratio (Davenport et al.,
2019). Our work shows that augmenting GABAergic signaling
in adult flies through genetic or pharmacological approaches,
including treatment with theGABAAR receptor-positive allosteric
modulator diazepam (valium), fully normalizes abnormal socialFigure 6. Social Deficits in Cyfip85.1/+ Flies Are due to Defects in GABA
(A–C) Abrogation of CYFIP in cholinergic (A) and GABAergic (B) neurons and in s
(LN1Gal4 and LN2Gal4), and theDPMneurons (DPMGal4). Flies were analyzed for
8 flies per genotype; ****p < 0.0001, **p < 0.01, Kruskal-Wallis test, Dunn’s multi
(D) Left: representative Z projections of confocal images of control andCyfip85.1/+
Right: data quantification (n = 15 brains). Scale bar, 100 mm. Mean ± SEM ****p
(E) Expression of UAS-synaptopHluorin in GABAergic neurons to measure synap
(F) Dynamics and integration of synaptopHluorin fluorescence in GABAergic neur
*p < 0.05, two-sample t test.
(G) GABA levels determined by HILIC-MS/MS in control and Cyfip85.1/+ brains. n
(H) Analysis of GABA levels from control and Cyfip85.1/+ flies into enriched fract
Kruskal-Wallis test, Dunn’s multiple comparison test. Numbers above the colum
(I) Competition for food of Cyfip85.1/+ flies upon treatment (2–5 days) with 50 mMG
Dunn’s multiple comparison test.behavior (Figure S6). Combined, these findings suggest a
common pathophysiological mechanism in these neurological
disorders that starts with GABA impairment and leads to social
deficits. However, despite past evidence of abnormal GABA
signaling in ASD (Ben-Ari et al., 2012; Cellot and Cherubini,
2014) and indications that cortical inhibitory neurons exhibit
enrichment in ASD risk gene expression (Wang et al., 2018), it
has remained unclear how alterations in GABA and E/I balance
occur in these disorders.
Mitochondrial Activity Modulates GABA Availability via
Aralar
Here we demonstrate that an increase in mitochondrial meta-
bolism causes GABA to be sequestered into mitochondria.
Translocation of GABA reduces the amount of GABA available
for vesicular uptake (Figure 6), likely affecting neuronal activity.
In fact, our observations are best explained by an effort of the
GABAergic circuit to homeostatically correct low GABA release:
the number of released vesicles is increased (Figure 6), and the
GABAAR receptor is overexpressed (data not shown; see also
Davenport et al., 2019). Reduced GABAergic transmission then
affects behavior (Figures 1 and 7).
To enter mitochondria, GABA needs to be transported across
the mitochondrial membrane. To date, a mitochondrial GABA
carrier has not been identified in any organism except in plants
(Michaeli et al., 2011). Here we screened candidate transporters
for rescue of the aberrant social behavior of Cyfip mutant flies,
leading to identification of the protein Aralar, which, as we
went on to show, is responsible for GABA uptake into the mito-
chondria in Drosophila (Figure 7). This work strengthens the
link between mitochondrial function, GABA transmission, and
social behavior.
Aralar belongs to the SLC25 family, the largest family of solute
transporters that consists mainly of mitochondrial proteins (Pal-
mieri, 2013; Zorova et al., 2018). Aralar homologs are present in
all metazoans (Amoedo et al., 2016), including two human homo-
logs: SLC25A12 (AGC1) and SLC25A13 (AGC2). Aralar trans-
porters have so far been shown to function by exchanging an
aspartate in the mitochondrial matrix for a glutamate plus a pro-
ton on the cytosolic side, with the pH gradient across the inner
membrane forming the bioenergetic driving force for solute ex-
change. As the major aspartate exporter from the mitochon-
drion, Aralar proteins play a major role in the malate-aspartate
shuttle that carries redox equivalents across the mitochondrialSignaling
ubsets of interneurons (C) namely in APL neurons (APLGal4), AL interneurons
total number of social interactions in a food competition assay. n = 14 groups of
ple comparison test.
andCyfip85.1/+ flies fed for 5 days with 50 mMGABA and stained with a-GABA.
< 0.0001, Kruskal-Wallis test, Dunn’s multiple comparison test.
tic release.
ons of control and Cyfip85.1/+ flies. n = 10 flies. All traces indicate mean ± SEM.
= 5 (groups of 10 brains) per genotype, mean ± SEM, Mann-Whitney test.
ions of mitochondria and vesicles by ELISA. n > 3, mean ± SEM. **p < 0.01,
ns indicate p values.
ABA; n > 10 groups of 8 flies; ****p < 0.0001, ***p < 0.001, Kruskal-Wallis test,

















































































































































































































































































































































































































































Figure 7. Aralar Affects Mitochondrial GABA Transport
(A) Genetic screening for changes in competition for food behavior. Flies mutant for mitochondrial carriers were crossed withCyfip85.1/+mutant flies, tested, and
compared with control and Cyfip85.1/+ flies. A threshold line indicates the control levels of behavior. # indicates the genotype that is significantly different from
Cyfip85.1/+ and not different from the control. Mean ± SEM, n > 10 groups of 8 flies, Kruskal-Wallis test, Dunn’s multiple comparison test.
(B–D) Competition for food (B), grooming behavior (C), and social space behavior (D) in control, Cyfip85.1/+, and AralarMI07552/Cyfip85.1 flies. n > 8 independent
experiments with groups of 8 and 30 flies in (B) and (D), respectively. All comparisons refer to the control. ***p < 0.001, **p < 0.01, *p < 0.05, Kruskal-Wallis test,
Dunn’s multiple comparison test.
(legend continued on next page)
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membrane and, thus, align the redox potential of the mitochon-
dria and the cytosol (Amoedo et al., 2016; Palmieri, 2013). Our
study now indicates that Aralar can also transport GABA, in addi-
tion to glutamate, despite the lack of one carboxylic group that
seems to be dispensable for binding to the transporter.
Neither the Aralar mRNA level nor its translational efficiency
changes between the two genotypes (Figure S7), indicating
that its expression is not altered in Cyfip mutant brains. Instead,
the activity of the Aralar transporter changes. Because Aralar
needs a proton for import of its substrate into mitochondria,
the equilibrium distribution of the transport substrates is set by
the pH gradient across the mitochondrial membrane, which, in
turn, is a function of fuel availability, OXPHOS, and activity of
the TCA cycle. Treatment with oligomycin (a highly specific inhib-
itor of complex V that increases the pH gradient) caused accu-
mulation of GABA in mitochondria and affected social behavior
(Figure 7).
Because CYFIP regulates protein synthesis (De Rubeis et al.,
2013; Genheden et al., 2015; Napoli et al., 2008; Oguro-Ando
et al., 2015; Panja et al., 2014; Santini et al., 2017) we hypoth-
esize that it regulates the translation of a subsets of mRNAs en-
coding proteins involved in mitochondrial activity. Future
studies are required to address which mRNAs are directly
controlled by CYFIP. In support of our hypothesis, in Cyfip mu-
tants, two key enzymes of the TCA cycle, IDH and aKG, are up-
regulated at the protein (Figure S2; Table S1) and activity levels
(Figure 4). Furthermore, mitochondria in Cyfip mutant brains
show a morphology (Figure 3) that is typical of hyperactive
mitochondria with a larger perimeter and area (Yao et al.,
2019). Interestingly, we show that alterations to the TCA cycle
via overexpression of the IDH enzyme causes social aberra-
tions comparable with those of Cyfip mutant flies (Figure 5).
Further, pharmacological or genetic inhibition of the IDH
enzyme normalizes the increased mitochondrial activity
observed in Cyfip mutant flies and ameliorates their social def-
icits (Figure 5). These data provide further support for a link be-
tween mitochondrial function, GABA transmission, and social
behavior. Additionally, both human Aralar homologs have cal-
cium-binding motifs in their cytosolic domain, and cytosolic
calcium robustly increases transport activity (Napolioni et al.,
2011); the calcium-binding motifs are conserved in Drosophila
Aralar. Therefore, the local calcium increases observed during
pre-synaptic vesicle release may well be sufficient to trigger
the GABA transport process, with local mitochondria respond-
ing to reduce local GABA availability. Thus, mitochondrial activ-
ity and high calcium, effects of increased neurotransmission,
can effectively reduce GABAergic neurotransmission. This sug-
gests that, under physiological conditions, Aralar-mediated
GABA sequestration is likely to serve as a homeostatic feed-
back inhibition mechanism. In addition, every other physiolog-
ical mechanism that increases the mitochondrial membrane
potential will reduce GABAergic transmission.(E) Analysis of GABA levels by ELISA in cytosolic and mitochondrial fractions fr
mean. **p < 0.01, *p < 0.05, Kruskal-Wallis test, Dunn’s multiple comparison tes
(F) Upon treatment with 500 mM oligomycin, mitochondrial membrane potential w
(G) Competition for food of control flies upon treatment (1 day) with 500 mM of o
(H) GABA levels measured by ELISA in fractionated mitochondria. n = 5, mean ±Disturbances of Mitochondrial GABA Control Affect
Social Behavior
Our data demonstrate a pivotal role of mitochondrial metabolism
dysregulation and the associated sequestration of GABA into
mitochondria in causing social behavioral deficits. Restoring
mitochondrial membrane potential by a variety of pharmacolog-
ical or genetic means rescues social behavioral deficits because
of Cyfip haploinsufficiency (Figure 5). Thus, our data might
explain, in molecular terms, the positive effects of some antipsy-
chotic drugs, such as haloperidol, chlorpromazine, fluphenazine,
or risperidone, on patients with ASD and SCZ that lead to a
decrease in mitochondrial respiration and membrane potential
(Balijepalli et al., 1999).
The Aralarmutation that increases cytosolic GABA levels (Fig-
ure 7E) also affects social behavior, similar to the Cyfipmutation
(Figures 7B and 7C), whereas the double mutation normalizes
cytosolic GABA levels and rescues social behavior. Moreover,
GABA administration to control animals reduces social behavior
(Figure S6). Taken together, this suggests a precarious equilib-
riumwhere too little or toomuch GABA availability is detrimental.
Thus, our findings predict that disturbances of mitochondrial
function cause pathological alterations in social behavior and
explain the well-established link between mitochondrial
dysfunction and ASD (reviewed in Hollis et al., 2017). Although
mitochondrial dysfunction may affect the nervous system in
various ways, our model predicts that Aralar should be specif-
ically linked to social disorders. Interestingly, two ASD-associ-
ated SNPs have been uncovered in AGC1/SLC25A12, the
human Aralar isoform that is known to be expressed in neurons
(see Aoki and Cortese, 2016, for a meta-analysis; Pardo et al.,
2013), and AGC1 expression is upregulated in the prefrontal cor-
tex of ASD patients (Anitha et al., 2012; Lepagnol-Bestel et al.,
2008). Further, disruption of the gene in mice causes hypomyeli-
nation and abnormal neurofilament accumulation (Sakurai et al.,
2010); more subtle changes in AGC1 activity are thus likely to
alter brain development and cause ASD.
This study provides causal evidence linking mitochondrial en-
ergy production through the TCA cycle to alterations in GABA
metabolism and further uncovers a mechanistic link between
these molecular processes and alterations in behavior in social
groups. Because alterations in mitochondrial metabolism are a
hallmark of diverse neurodevelopmental disorders in humans,
our findings could represent a common mechanism underlying
social deficits in these disorders, and it has the potential to be
relevant for physiological regulation of neurotransmission and
also for a wide range of neurodevelopmental and neuropsychi-
atric disorders. Our study demonstrates that social deficits in
our fly model can be rescued by pharmacological dampening
of mitochondrial respiration because this modulates Aralar activ-
ity. Therefore, molecules that specifically activate or inhibit
human Aralar should be considered as potential therapeutic ap-
proaches for treatment of these disorders.om control, Cyfip85.1/+, AralarMI07552/+, and AralarMI07552/Cyfip85.1 flies. n > 3,
t.
as analyzed by staining using TMRE; n = 8–9 brains.
ligomycin; n = 10 groups of 8 flies each.
SEM, ***p < 0.001, *p < 0.05, Kruskal-Wallis test.
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mate, GABA and acetylcholine signaling components in the lamina of the
Drosophila visual system. PLoS ONE 3, e2110.
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Pardo, B., Contreras, L., and Satrústegui, J. (2013). De novo Synthesis of Glial
Glutamate and Glutamine in Young Mice Requires Aspartate Provided by the
Neuronal Mitochondrial Aspartate-Glutamate Carrier Aralar/AGC1. Front. En-
docrinol. (Lausanne) 4, 149.
Pathania, M., Davenport, E.C., Muir, J., Sheehan, D.F., López-Doménech, G.,
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Critical Commercial Assays
NAD/NADH Quantitation Colorimetric Kit BioVision Cat #K337
Isocitrate Dehydrogenase Activity Colorimetric Assay Kit BioVision Cat #K756
GABA ELISA Kit IBL International Cat #ID59301
Citrate Synthase Activity Assay Kit Sigma-Aldrich Cat #MAK193
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Drosophila: Canton-S w1118 (iso1CJ) Kanellopoulos et al., 2012;
E.M.C. Skoulakis
N/A
Drosophila: Cyfip85.1/TM3, Sb Schenck et al., 2003;
A. Giangrande
N/A
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N/A
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E.M.C. Skoulakis
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Drosophila: DPM-Gal4 E.M.C. Skoulakis N/A
Drosophila: UAS-synaptophysin-GCaMP3 Pech et al., 2015; A. Fiala N/A
Drosophila: APL-Gal4 E.M.C. Skoulakis N/A
Drosophila: UAS-synaptopHluorin A. Fiala N/A
Drosophila: Pink1B9 Morais et al., 2009; P. Verstreken RRID: BDSC_34749
Drosophila: NDUFS3(Ex2)/TM3, Sb B. Graham N/A
Drosophila: Idh3a3 Ugur et al., 2017; H. Bellen RRID: BDSC_57095
Drosophila: UAS-Idh3aVK00033 Ugur et al., 2017; H. Bellen RRID: BDSC_80142
Drosophila: Aralar1MI07552 Bloomington Drosophila
Stock Center (BDSC)
RRID: BDSC_43727
Drosophila: sesBEP319 BDSC RRID: BDSC_10108
Drosophila: prelk12402, l(2)k12402k12402/CyO BDSC RRID: BDSC_11059
Drosophila: Ant2G0126, sesBG0126/FM7c BDSC RRID: BDSC_11830
Drosophila: Mpcp200564]/TM3, ry Sb Ser BDSC RRID: BDSC_11502
Drosophila: mgeA1/TM6B, Tb BDSC RRID: BDSC_5169
Drosophila: mfrnBG00456 BDSC RRID: BDSC_12489
Drosophila: lz-90b24/FM7c BDSC RRID: BDSC_3651
Drosophila: BmcpBG02446 BDSC RRID: BDSC_12688
Drosophila: GC1MB02413 BDSC RRID: BDSC_23971
Drosophila: CG7514c04924 BDSC RRID: BDSC_17274
Drosophila: MME1G2643 BDSC RRID: BDSC_27001
Drosophila: CG1907G17905 BDSC RRID: BDSC_33332
Drosophila: CG18418MI12954 BDSC RRID: BDSC_58012
Drosophila: Mpcp1TKO.GS00980}attP40 BDSC RRID: BDSC_76529
Drosophila: Hmt-1LA00983 BDSC RRID: BDSC_22259
Drosophila: CG4743f03065 BDSC RRID: BDSC_18615
Drosophila: ABCB7EY15987/TM3, Sb Ser BDSC RRID: BDSC_21176
Drosophila: porink05123/CyO BDSC RRID: BDSC_10563
Drosophila: ScoxEY05333/CyO BDSC RRID: BDSC_16652
(Continued on next page)
Cell 180, 1178–1197.e1–e9, March 19, 2020 e2
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Drosophila: DPCoACEY11237/TM3, Sb Ser BDSC RRID: BDSC_20669
Drosophila: Tpc1f01677/TM6B, Tb BDSC RRID: BDSC_18456
Drosophila: seiHP21840 BDSC RRID: BDSC_21935
Drosophila: CG31560MI05567 BDSC RRID: BDSC_42333
Drosophila: MCUEY01803 BDSC RRID: BDSC_16357
Drosophila: CG45085MI13652 CG8026MI13652/SM6a BDSC RRID: BDSC_59176
Drosophila: Mpc1d00809 BDSC RRID: BDSC_19149
Drosophila: EMREMI02464 BDSC RRID: BDSC_35091
Drosophila: CG9399MI15657 BDSC RRID: BDSC_61119
Drosophila: CG1628KG08894 BDSC RRID: BDSC_14775
Drosophila: Letm1MB02246/SM6a BDSC RRID: BDSC_23794
Drosophila: MiroG6613 BDSC RRID: BDSC_30172
Drosophila: Cln3MB06009 BDSC RRID: BDSC_27741
Drosophila: coltG2414 BDSC RRID: BDSC_26993
Drosophila: CG1824GG01740 BDSC RRID: BDSC_19929
Drosophila: UAS-mCD8::GFP.L}LL5 BDSC RRID: BDSC_5137
Oligonucleotides
Cyfip forward primer: ACGGAACCACAGACGCTAGT this paper N/A
Cyfip reverse primer: ACCCATGAAAGCATCCACTT this paper N/A
Gad forward primer: GGACTGTGCCACCACATTGA this paper N/A
Gad reverse primer: GCCATGGAGATCAGGTCCAG this paper N/A
rpl13 forward primer: GTGGTCGAGTTCCGTGAGG this paper N/A
rpl13 reverse primer: CCTTCTTGGGGTCTCCCTT this paper N/A
rpl32 forward primer: AGCATACAGGCCCAAGATCG this paper N/A
rpl32 reverse primer: TGTTGTCGATACCCTTGGGC this paper N/A
mitochondria 16S forward primer: AAAAAGATTGCGACCTCGAT this paper N/A
mitochondria 16S reverse primer: AAACCAACCTGGCTTACACC this paper N/A
Aralar forward primer: TCCTGGGACTCTTTTCCGAAT this paper N/A
Aralar reverse primer: GCCTGGAACTCCGAGAAGG this paper N/A
Firefly luciferase forward primer: ATCTGCCTCCTGGCTTCAAC this paper N/A
Firefly luciferase reverse primer CGGTAGACCCAGAGCTGTTC this paper N/A
Software and Algorithms
ImageJ NIH RRID: SCR_002285
Adobe Illustrator 2019 Adobe RRID: SCR_010279
GraphPad Prism 8 GraphPad Software RRID: SCR_002798
Microsoft Excel 2019 Microsoft corporation RRID: SCR_016137
DAMSystems308 Trikinetics RRID: SCR_016191
Rstudio R RRID: SCR_000432LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Prof.
Claudia Bagni (claudia.bagni@unil.ch). There are restrictions to the availability of Cyfipmutant flies due to a signed MTA with Dr. An-
gela Giangrande (co-author in this manuscript).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Drosophila stocks and rearing conditions
Flies were cultured in vials containing a standardDrosophilamedium at 25Cwith 60%–80%humidity in a 12h light/dark cycle. The fly
line used as control was wild-type Canton-S w1118 (iso1CJ). Heterozygous mutant flies for Cyfip (Cyfip85.1/+) lacking two-third of thee3 Cell 180, 1178–1197.e1–e9, March 19, 2020
Cyfip-coding region were described previously by Schenck et al. (2003). The Cyfip85.1/+mutant flies used in this study were isogen-
ized for 6 generations with a Cantonized w1118 background. Regulation of CYFIP expression was achieved using the tissue specific
GAL4/UAS system (Brand and Perrimon, 1993). In this study, to abrogate the levels of CYFIP we used the UAS-Cyfip-RNAi (UAS-
Cyfip-IR) transgene as described before (Galy et al., 2011), GAL4 in turn will bind the Upstream Activation Sequence (UAS). As a
result, the RNAi construct is transcribed and endogenous Cyfip transcript will be downregulated. GAL4/GAL4 females were crossed
en masse to UAS-Cyfip-IR/UAS-Cyfip-IR males to generate GAL4/UAS-Cyfip-IR progeny. GAL4/GAL4 and UAS-Cyfip-IR/UAS-
Cyfip-IR females were also crossed with w1118 males to generate GAL4/+ and UAS-Cyfip-IR/+ progeny respectively that served
as controls. Tissue-specific GAL4 expression was achieved using the tissue-specific GAL4 promoters as follows: pan-neuronal
(Elav), cholinergic (Cha-Gla4), and GABAergic (Gad-Gal4). To avoid neurodevelopmental problems and possible lethality, ElavGal4
was combined with the temporal TubGal80ts system (McGuire et al., 2003, 2004). At 18C, TubGal80ts is active and binds GAL4, pro-
hibiting its binding to the UAS (i.e., no transcription of UAS-Cyfip-IR). In contrast, at 29-30CTubGal80ts is inactive andGAL4will bind
the UAS thus activating transcription of UAS-Cyfip-IR. As a result, expression of CYFIP will be downregulated. All flies/progeny for
promoter-Gal4;TubGal80ts and their controls were cultured at 18C and 2-days after eclosion were placed at 29-30C allowing UAS-
Cyfip-IR transcription. For Ca2+ imaging, flies were generated that express either synaptophysin-GCaMP (Pech et al., 2015) under
control of the specific promoter GAL4 line (Zars et al., 2000). The Ca2+ sensors were PCR-amplified from pUAST vectors (Pech
et al., 2015). The w pink1B9 flies were kindly provided by Patrik Verstreken (VIB/KULeuven) and described in Morais et al. (2009).
The ndufs3 flies were kindly provided by Brett Graham (Baylor College of Medicine, Houston) and the idh3a flies described in
Ugur et al. (2017) were a gift from Hugo Bellen (Baylor College of Medicine, Houston). All the other transgenic flies used in this study
were purchased from the Bloomington stock center. Adult male flies (3-7 days old) were used in all the experiments unless differen-
tially specified in the text.
All the behavioral experiments in flies were performed in awalk-in chamber by Fitoclima Aralab (https://www.aralab.pt/), that offers
highly precise and reproducible conditions for climatic and temperature testing.
METHOD DETAILS
Drosophila single Pair Mating Assay
Social performance of the Cyfip85.1/+ flies was investigated by observing courtship, a complex innate Drosophila behavior. Briefly,
courting Drosophila males perform a characteristic sequence of behaviors: orienting toward and following the female, tapping her
with their forelegs, vibrating one wing, licking her genitalia, and attempting to copulate (Bastock, 1956; Bastock and Manning,
1955; Ejima and Griffith, 2007; Sokolowski, 2001, 2010).
Five to seven days-old virginmales and females were used. Each assay consisted of oneCyfip85.1/+male and onewild-type female
introduced into a plexiglass-mating chamber (1 cm diameter3 4 mm height). The courtship activities were video recorded until suc-
cessful copulation, or longer (6minutes) in the absence of copulation, using a 65XSDcamcorder (Samsung)mounted on a tripod. The
assayswere done under ambient light at 22C temperature and 70%humidity. From the video recordings the courtship index (CI) was
calculated for eachmale. Briefly, CI is the fraction of total recording time the male performed courtship behaviors (orienting, chasing,
tapping, licking, singing, copulation attempts) (Ejima and Griffith, 2007; Siegel and Hall, 1979; Sokolowski, 2001, 2010).
Drosophila quantitative assay for social events (competition for food)
Assays were performed on socially experienced, 3–7 days-old male flies. Groups of eight males from the same genotype were anes-
thetized 24 h prior to the assay and placed in vials with food. On the day of the assay, themaleswere transferredwithout anesthesia to
an empty vial and were deprived of food for 90minutes, after which they were exposed to a food droplet and given 2minutes to accli-
mate to this disturbance. The flies were then observed for an additional 2-minutes, and the total number of social event encounters
scored. Behavioral assays were conducted in a behavioral chamber (25C, 60%–70% humidity) between 8 a.m. and 11 a.m. Statis-
tics were calculated using a one-way fixed effect ANOVAmodel, Kruskal Wallis test in combination with Dunn’s multiple comparison
test. A group of male flies were tested simultaneously to obtain an average of the total number of social events in 2minutes (i.e., num-
ber of total approaches, lunges, tussles, wing threat and initiation of courtship scored) (Dankert et al., 2009). The index of approaches
in such a complex set up (8 flies) was used to quantify behavior.
Grooming behavior
Flies of 5 days old were collected the day before the assay and kept in vials with fresh food. The day of the experiment they were
anesthetized by placing them on ice for 2 min and then placed into a grooming chamber (circular arena of 1cm diameter). Flies
were allowed for 20 min to acclimate and then grooming activity was recorded for 3 min, using a 65X SD camcorder (Samsung)
mounted on a tripod. Tomeasure grooming behavior, raw videos were analyzed blind to the genotype, calculating the time of groom-
ing over 3 min.
Social space behavior
Flies were separated by gender the day prior to each experiment and kept in vials with fresh food. The analysis of social space
behavior was performed using a horizontal circular chamber (a Petri dish of 9 cm diameter) as described before (Simon et al.,Cell 180, 1178–1197.e1–e9, March 19, 2020 e4
2012). Flies were briefly anesthetized by placing them on ice for 2 min and placed into the chamber. Flies were allowed to acclimate
for 10min and then digital images were collected after the flies reached a stable position (up to 25min). Digital images were imported
in ImageJ and an automated measure of the nearest neighbor to each fly was determined using our own custom R script (available
upon request).
Thigmotaxis behavior, refers to the tendency of flies to move closer to the wall of an open arena to avoid the central part (more
threatening, centrophobicity) (Besson and Martin, 2005). The distance of a fly from the wall of the chamber was measured using
our own custom R script. Graphs and statistical analysis were performed using Prism 8 (GraphPad Software, San Diego, CA, USA).
Negative geotaxis experiment
The negative geotaxis experiment allows to evaluate the reflexmotor response inDrosophila as previously described (Kosmidis et al.,
2011). Briefly, 2-days-old control and Cyfip85.1/+ flies were transferred individually into polystyrene tubes. The flies were allowed to
acclimate for 10 min in a dark environment of 25C and 70%–80% humidity illuminated by red light. Each fly was vortexed for 2 s and
tested twice for negative geotaxis measuring the time the fly climbs the distance of 6 cm.
Food intake assay
A colorimetric estimation of food intake was performed as previously described (Aditi et al., 2016) with some modifications. Briefly
groups of 7-days old matedmale flies, entrained under 12:12 LD (Light-dark cycle), were transferred onto food containing 2.5% (w/v)
food dye (Erioglaucine blue disodium salt; Sigma-Aldrich), 2% agar and 5% sucrose, and left to feed ad libitum for 2 hours. After
feeding the flies were washed with PBS 1X, each body was detached from the head and individually homogenized in 100 mL of chilled
PBS 1X and centrifuged at 10.000 rpm for 10 min. 50 mL of supernatant was used for absorbance recording at 620nm using a
spectrophotometer.
Drosophila locomotor activity
The Drosophila Activity Monitoring (DAM) system from Trikinetics Inc. (Walthman, MA) was used to record the locomotor activity of
flies. Male flies (1-week old), anesthetised on ice, were individually loaded into the locomotor activity-monitoring tubes, thin 5 mm
diameter polycarbonate tubes containing 5% sucrose and 2% agar food and incubated for at least 4 days under 12:12 LD (light -
dark) conditions at 25C and 50%–60% humidity. Light was turned on at 7:30 am and turned off at 7:30 pm. The DAM system
software counts the number of times the single fly walks through an infrared beam aimed at the middle of the tube. Data were
recorded as the number of crossings (transitions) per bin of 5-30 minutes. The first day was excluded from the analysis to allow
the flies to recover from anesthesia and to get acclimatized to the new environment. Two independent experiments were
performed and at least 40 flies for each genotype were analyzed. Statistical analysis was conducted using GraphPad Prism
8.0 software. Data were evaluated by one-way analysis of variance (ANOVA) with Sidak’s post hoc test and by non-parametric
Kruskal-Wallis’s test with Dunn’s correction.
Western Blotting analysis
For western blot analysis, male fly heads were homogenized in 2x Laemmli buffer containing DTT. They were loaded on 10% acryl-
amide gels, transferred to PVDF membranes and probed with primary antibodies. The primary antibodies used: anti-Syntaxin
(DSHB) at 1:3000, anti-GAD1 (kind gift of Prof. Rob Jackson), anti-ATP5B (Abcam) at 1:4000, anti-NDUFS3 (Abcam) at 1:4000,
anti-HSP60 (Santa Cruz) at 1:4000, anti-Tom20 (Santa Cruz Biotech) at 1:1000, anti-VDAC/Porin (Abcam) at 1:2000, anti-Bruch-
pilot (DSHB) at 1:500, and anti-Tubulin (DSHB) at 1:4000. Detection was obtained using the Odyssey infrared imaging system
(LI-COR, Bioscience). The fluorescent secondary antibodies DyLight 800 anti-rabbit and DyLight 800 anti-mouse were used at
1:5000 (Thermo Scientific).
RNA Extraction, RT-PCR and quantitative PCR (qPCR)
Total RNA was extracted from 30 male 1-week-old fly heads using Trizol reagent (Invitrogen, Carlsbad, CA) according to
manufacturer’s instructions. Before proceeding with the RT-PCR, RNA quantity and quality were determined with the NanoDrop
2000 UV-Vis Spectrophotometer (Thermo, USA). Four independent samples for each genotype and 2 biological replicates have
been collected.
Total RNA was diluted to prepare aliquots of 200 ng/10 ml and used in RT-PCR reaction for 1 h at 37C, using random primers,
M-MLV enzyme (Invitrogen), buffer 5x M-MLV reaction buffer, RNAase OUT and dNTPs, according to manufacturer’s instructions
(Invitrogen). cDNA was diluted 1:20 and 5 ml cDNA was used for each qPCR 15 ml reaction. qPCR was conducted on a Light Cycler
96 (Roche, Switzerland) with SYBR Green PCR mix (Roche, Switzerland) with primers of our genes of interest: Cyfip, gad, and ribo-
somal proteins L13 and L32 (encoding for the 60S ribosomal protein L13 and L32 respectively). All primer pairs were designed
through the Fly Primer Bank (https://www.flyrnai.org/flyprimerbank) and were synthesized by IDT (Belgium) and Microsynth AG
(Switzerland).
Two technical replicates for each biological replicate were assessed. Statistical analysis was conducted usingGraphPad Prism 8.0
software (La Jolla, CA). Data were evaluated by one-way analysis of variance (ANOVA) with Sidak’s post hoc test and by Kruskal-
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Quantitative PCR for mtDNA content. Drosophila whole DNA (genomic and mitochondrial) from adult brains was obtained using a
method previously described (Yoon et al., 2017). The isolated DNAwas used for qPCR as described above. Primers against themito-
chondrial ribosomal protein 16S and the ribosomal protein L13 were used to amplify mtDNA and genomic DNA respectively.
Polysomes/mRNPs gradient
The protocol was slightly modified fromNapoli et al. (2008). Specifically,Drosophila heads were homogenized in lysis buffer (100mM
NaCl, 10 mMMgCl2, 10 mM Tris-HCL pH 7.5, 0.5 mM DTT, Protease inhibitor cocktail, 50 mg/mL CHX, RNase OUT and RNAsin in-
hibitor 2.5 ml/mL). The lysates were incubated 5min on ice and then centrifuged 5min at 1000 g. In the supernatant Triton-X 20% and
NaDoc 10% were added to the supernatant. Samples were then centrifuged 8 min at 12000 g at 4C and the supernatants centri-
fuged through 15%–50% (w/v) sucrose grandients for 2 hours at 37.000 rpm. Gradients were collected in 12 fractions. Equal volumes
from each fraction were used for RNA extraction using Phenol-Chloroform-Isoamyl alchool (according tomanufacturer’s conditions).
2 pg/ml of spike in Firefly Luciferase (FLuc) mRNA, (Promega) was added as loading control. The mRNA was used for RT and quan-
titative PCR as described in themanuscript. AralarmRNA level (Aralar primer For: TCCTGGGACTCTTTTCCGAAT; Aralar primer Rev:
GCCTGGAACTCCGAGAAGG) was normalized to Fluc mRNA level (FLuc Primer For: ATCTGCCTCCTGGCTTCAAC; FLuc Primer
Rev: CGGTAGACCCAGAGCTGTTC).
Drosophila drug administration
All compounds were purchased from Sigma-Aldrich and were used as described before (Kanellopoulos et al., 2012; Zwarts
et al., 2011). The drugs were dissolved as per the manufacturer’s instructions and used at the following concentrations:
ML309 at 5 mM, GABA at 50 mM, DABA 100 mM, Valproic acid (VPA) at 1 mM, Diazepam at 50 mM, Rotenone at 1-10 mM, Pyr-
idoxal 50 phosphate (PLP) at 50 mM, and Oligomycin at 500 mM. Compounds in solution were mixed with Formula 4-24 Instant
Drosophila Medium (blue food) in water. Approximately 50–60 adult flies were placed in plastic vials containing 500 mL of each
solution on top of an agar matrix and allowed to feed ad libitum before behavior. Vehicle treatment consisted of solvent added
to blue food alone.
Immunohistochemical analysis
Fly brains were dissected under a stereomicroscope in phosphate-buffered saline 1x (PBS) for no longer than 1 hour and fixed in PBS
1x containing 3,7% formaldehyde for 10-15 minutes at room temperature using a rotator. After 3 washes of 10 minutes in PBT (PBS
1x, 0.3% Triton-X) the brains were blocked in 10% Normal Goat Serum in PBT for 30 minutes. The brains were then incubated with
anti-GABA (Sigma-Aldrich) at 1:500, anti-nc82 (DSHB) at 1:500, anti-GAD (DSHB) at 1:250, in 5%NGS in PBT at 4C overnight. After
the primary antibody incubation, the brains were washed in PBT 3 times for 10 minutes per wash and incubated with secondaries
Alexa Fluro 546 or 488 (Life Technologies, USA) at 1:1000 in 5%NGS in PBT for 1-2 hours at room temperature (RT). Then the brains
were washed again in PBT for 3 times at RT for 10minutes andmounted inMowiol containing DAPI (1:1000) on a glass slide. Pictures
were taken on the Olympus FluoView FV1000 Confocal Microscope and analyzed with ImageJ software.
For the TMRE (Enzo) and Rhodamine 123 (Sigma-Aldrich) stainings, brains were dissected in HL3 solution (mM): 110 NaCl, 5 KCl,
10 NaHCO3, 5 HEPES, 30 sucrose, 5 trehalose, and 10 MgCl2, pH 7.2. Dissected brains were stained with 10nM TMRE or Rhoda-
mine123 dye for 5 minutes at room temperature. Brains were quickly washed with HL3 solution, mounted on glass slides and imme-
diately imaged with confocal microscope Leica SP8 using the same settings for all the samples.
FACS Analysis
To isolate the GABAergic neuronal population fromDrosophila brain, the enhancer-trap line Gad-GAL4 was used to drive the expres-
sion of GFP in GABAergic neurons of control and Cyfip85.1/+ flies. Brains from adult flies (n = 60) per genotype were dissected in cold
1xPBS. Tissues were dissociated using 0.05% trypsin-EDTA (Life Technologies) for 60minutes at 37C in the dark. The GFP-positive
cells were fractionated from theGFP negative population using a BD FACSAria I by BDBiosciences (San Jose) with a 70 mmnozzle tip
at 60psi. GFP was excited by a blue laser (488nm) and detected using a 530/30 bandpass (BP) filter. Dead cells were excluded using
propidium iodide (PI) at a final concentration of 1 mg/ml and detected using a 610/20 BP filter. Post sort purity checkwas performed to
ensure clean fractionation of both the GFP-positive and -negative populations. Data were analyzed and presented with FlowJo soft-
ware (Tree Star, Ashland, OR).
Functional Imaging
Control and Cyfip85.1/+ flies were generated to express the synaptically targeted Ca2+ sensitive fluorescent protein G-CaMP3 or the
vesicle-release reporter synaptopHluorin in the GABAergic neurons. Brains of male transgenic flies (seven days old) expressing syn-
aptophysin-GCaMP (Pech et al., 2015) or synaptopHluorin (Ng et al., 2002) were imaged at a frame rate of 5 Hz and for 100 ms per
frame at 488 nm through a window cut into the head capsule using an upright fluorescence microscope (Zeiss Examiner D1)
equipped with a xenon lamp (Lambda DG-4, Sutter Instrument), a 14-bit CCD camera (Coolsnap HQ, Photometrics) and a 203 wa-
ter-immersion objective (NA = 1.0). 50 ml of freshly prepared 1M KCl were injected into the Ringer’s solution covering the brain (final
concentration at the brain 0.05M). Image acquisition was controlled using the software Metafluor (Visitron Systems, Puchheim).
Image processing and analysis was performed with Fiji software. Circular regions of interest (ROIs, diameter 20 mm) were placed
in the center of the calyx or on the lobes. Background fluorescence outside the neuropils was subtracted from each ROI, ‘‘F0’’ was
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in each frame and F0, and resulting values were normalized by dividing by F0. The experimental flies were heterozygous for the sensor
in either thew1118 background only or carrying the Cyfip85.1/+mutation. Both controls and mutant flies were measured alternately on
the same days.
Mass Spectrometry
Sample was dissolved in Laemmli buffer and run on a 10% SDS-PAGE gel, which was stopped when the front reached about 1/5 of
the gel. The gel was fixed overnight and stained briefly with colloidal Coomassie blue. The protein-containing gel piece was chopped
into 1mm by 1mm pieces, destained, and subjected to trypsin digestion as described previously (Chen et al., 2015). The tryptic pep-
tides were dissolved in 17 mL 0.1M acetic acid, and analyzed by nano-LCMS/MS using an Ultimate 3000 LC system (Dionex, Thermo
Scientific) coupled to a TripleTOF 5600 mass spectrometer (Sciex). Peptides were fractionated on a 200 mm Alltima C18 column
(100 mm i.d., 3 mm particle size). The acetonitrile concentration in the mobile phase was increased from 5 to 30% in 90 minutes,
to 40% in 5 minutes, and to 90% in another 5 minutes, at a flow rate of 400 nL/minutes. The eluted peptides were electro-sprayed
into the TripleTOF MS. The nano-spray needle voltage was set to 2500V. The mass spectrometer was operated in a data-dependent
mode with a single MS full scan (m/z 3501200, 250 msec) followed by a top 25 MS/MS (85 msec per MS/MS, precursor ion > 90
counts/s, charge state from +2 to +5) with an exclusion time of 16 s once the peptide was fragmented. Ions were fragmented in the
collision cell using rolling collision energy, and a spread energy of 10eV. The MS raw data were imported into MaxQuant (version
1.5.2.8), and searched against the uniprot-proteome_fruitfly_%3AUP000000803 database, withmatch between run enabled. Further
MaxQuant settings were left at default.
Database analysis
Orthology mapping was obtained using the DRSC DIOPT tool (Hu et al., 2011) that makes use of the following resources: Ensembl
Compara (Vilella et al., 2009), NCBI Homologene, Inparanoid, Isobase, OMA, OrthoDB, OrthoMCL, Phylome, RoundUp and
TreeFam.
Disease Enrichment
We investigated disease enrichment of the union dataset (mapped to 278 human genes) using gene-disease annotation data
collected from OMIM (Amberger et al., 2015), GeneRIF (Mitchell et al., 2003) and Ensembl variation (Chen et al., 2010a) databases
using the topOnto package (https://github.com/statbio/topOnto). The annotation data was standardized using MetaMap (Aronson
and Lang, 2010) and NCBO Annotator to recognize terms found in the Human Disease Ontology (HDO) (Schriml et al., 2012). Recog-
nized disease ontology terms were then associated with gene identifiers and stored locally. Disease term enrichment for the 279 hu-
man genes was then calculated using the Topology-based Elimination Fisher method (Alexa et al., 2006) found in the topGO package
(https://topgo.bioinf.mpi-inf.mpg.de/), together with the standardized OMIM/GeneRIF/Ensembl variation gene-disease annotation
data (17731 gene-disease associations), and the full HDO tree (3140 terms). We tested the dataset for functional enrichment using
the GO Cellular Component (CC) and Biological Function (BP) ontologies (Ashburner et al., 2000), together with the topGO package
and Elimination Fisher method. We found 1078 (1692) CC terms for Fly (Human) and 6479 (14291) BP terms (See Tables S1, S2, and
S3). Enrichment results are shown in Figure 2, where P values have been corrected using the Bonferroni correction at the 0.01 (***) and
0.05 (**) significance level, using the number of terms in the GO tree.
Construction of PPI networks from external Databases
The fly PPI network was built using the total 361 genes found, together with interactions extracted from the publicly available data-
bases: FlyBase, BioGRID, IntAct, BIND, DIP, MINT.The fly PPI network was filtered to contain only interactions between the 361
genes. The final largest connected component contains 274 genes and 1014 interactions. The network was found to have overall
associative mixing (0.097), driven by main contributors BioGRID (0.187) and FlyBase (0.85). The corresponding human PPI network
built from the 278 human orthologs, was found to consist of 234 genes and 1143 interactions.
The fly PPI network consisting of 274 genes and 1014 interactions, using the Vision visualization package (https://visone.info/) and
clustered using the Modularity based Potts model and simulated annealing algorithm ‘‘spinglass’’ (Reichardt and Bornholdt, 2006;
Traag and Bruggeman, 2009) available in R (http://igraph.org/redirect.html) (spin states set to 500, and gamma to 2.0). Genes are
highlighted using GO annotation with ‘‘mitochondrion’’ (GO:0005739) related genes in peach, ‘‘cytoskeleton’’ related genes in
navy blue, and ‘‘synaptic vesicle’’ related genes in orange. For each cluster in the fly PPI network found, we further tested the sig-
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(eqn-1)Where in eqn-1, N is the total number of genes in the network; Cn the number of genes in the community; F the total number of func-
tional annotated genes in the network, and mfc the number of functional annotated genes per community. P values were tested fore7 Cell 180, 1178–1197.e1–e9, March 19, 2020
their strength of significance, by recording the percentage of P values found from every community/annotation combination, lower
than or equal to the observed P value, when 1000 random permutations of the annotation labels were made. A pseudocount of 1 was
added to avoid permutated P values of zero. P values found with a strength of significance < 1% were considered statistically
significant. Functionally enriched clusters, for GO ‘‘mitochondrion,’’ ‘‘cytoskeleton’’ and ‘‘synaptic vesicle’’ related annotations are
also highlighted. Gene ontology analysis for genetic screening. 178 Drosophila genes were associated with GO ‘‘mitochondrial outer
membrane’’ (GO:0005741). Out of 178, 43 genes were selected that were described to be involved in transport (excluding protons,
electrons transport andOXPHOS). From the 43 genes, 36 availablemutant fly strainswere obtained from the BloomingtonDrosophila
Stock Center (NIH P40OD018537) and used in this study.
Metabolite quantification
Both groups of metabolites, amino acids and TCA cycle intermediates, were quantified using stable-isotope-dilution Liquid Chroma-
tography Mass Spectrometry (LC-MS) as described below. Snap frozen brain samples were pre-extracted and homogenized by the
addition of 100 mL of MeOH:H2O (4:1) per 10 fly brains (23 20 s at 10000 rpm, Cryolys Precellys Homogenizer, Bertin Technologies,
Rockville, MD, US). Homogenized extracts were centrifuged (15 minutes at 4000 g at 4C) and the resulting supernatant was evap-
orated to dryness in a vacuum concentrator (LabConco, Missouri, US). Total protein content was measured in pellets using the BCA
assay. Dried sample extracts were resuspended in 50mL of MeOH:H2O (4:1, v/v) and mixed with 250mL of the ice-cold internal stan-
dard solution (in 100% acetonitrile). Samples were then incubated 30minutes at80C in order to promote protein precipitation and
centrifuged 15minutes at 4Cand 2700 g. The resulting supernatants were injected for LC-MS analysis. Quantification of amino acids
was performed using Hydrophilic Interaction Liquid Chromatography coupled to high resolution mass spectrometry (HILIC - HRMS)
in positive ionizationmode using aQExactive Hybrid Quadrupole-Orbitrap interfacedwith Thermo Accela 1250UPLCpump andCTC
PAL Analytics autosampler. Metabolites were separated using a BEH Amide, 1.7 mm, 100 mm 3 2.1 mm I.D. column (Waters,
Massachusetts, US). The mobile phase was composed of A = 20 mM ammonium formate and 0.1% FA in water and B = 0.1%
FA in ACN. The linear gradient elution from 95% B (0-2 minutes) to 65% B (14 minutes) and down to 50% B (16 – 18 minutes)
was applied, followed by 4 minutes of column re-equilibration in the initial gradient conditions. The flow rate was 400mL/minutes
and the sample injection volume was 10 mL. HESI source conditions were set as follow: sheath gas flow at 60, Aux gas flow rate
at 20, Sweep gas flow rate at 0, spray voltage at +3kV, capillary temperature at 300C, s-lens RF level at 60 and aux gas heater tem-
perature at 300C. The instrument was set to acquire over themass range 60900, with theMS acquisition parameters set as follows:
resolution at 70’000 FWHM, 1microscan, 1e6 AGC andmaximum inject time at 100ms. Amino acids and derivatives were quantified
by using a standard calibration curves and isotopic labeled internal standards. LC-MSdatawas processed using TraceFinder Clinical
Research (version 4.1, Thermo Fischer Scientific). Quantification of TCA cycle intermediates was performed using Hydrophilic Inter-
action Liquid Chromatography coupled to tandem mass spectrometry (HILIC - MS/MS) in negative ionization mode using a 6495
Triple Quadrupole system (QqQ) interfaced with 1290 UHPLC system (Agilent Technologies). TCAmetabolites were separated using
a ZIC-pHILIC (100 mm, 2.1 mm I.D. and 5 mm particle size) column. The mobile phase was composed of A = 20 mM ammonium
Acetate and 20 mM NH4OH in water at pH 9.35 and B = 100% ACN. The linear gradient elution from 90% B (0-1.5 minutes) to
50% B (8 – 11 minutes) and down to 45% B (12 – 15 minutes) was applied, followed by 9 minutes of column re-equilibration using
the initial gradient conditions. The flow rate was 300 mL/minutes, column temperature 30C and sample injection volume 2ml. ESI
source conditions were set as follows: dry gas temperature 290C and flow 14 L/minutes, sheath gas temperature 350C, nebulizer
45 psi, and flow 12 L/minutes, nozzle voltage 0 V, and capillary voltage2000 V. Data were acquired in a Dynamic Multiple Reaction
Monitoring (DMRM)modewith a total cycle time of 600msec. Collision energieswere optimized for eachmetabolite. LC-MS/MSdata
was processed using the Agilent Quantitative analysis software (version B.07.00, MassHunter Agilent technologies). Relative quan-
tification of metabolites was based on EIC (Extracted Ion Chromatogram) areas for the monitored MRM transitions. For absolute
quantification, calibration curves and the stable isotope-labeled internal standards (IS) were used and the concentrations of the com-
pounds were calculated as the ratio of MS response (peak area) between the analyte and the IS, to account for matrix effects. Finally,
the concentrations were reported to total protein content in brain tissue. For isotope tracing, flies were fed with sucrose free food
containing [U-13C]-glucose for 6 hours and immediately dissected in cold PBS 1x. For each sample ten Drosophila brains were
pre-extracted and homogenized as described above. Brain extracts were analyzed by Hydrophilic Interaction Liquid Chromatog-
raphy coupled to high resolution mass spectrometry (HILIC - HRMS) in negative ionization mode using a 6550 Quadrupole
Time-of-Flight (Q-TOF) system interfaced with 1290 UHPLC system (Agilent Technologies) as previously described (Gallart-Ayala
et al., 2018). Raw LC-MS files were processed in Profinder B.08.00 software (Agilent Technologies) using the targeted data mining
in isotopologue extraction mode. The metabolite identification was based on accurate mass and retention time matching against an
in-house database containing data on 600 polar metabolite standards (analyzed in the same analytical conditions). The Extracted Ion
Chromatogram areas (EICs) of each isotopologue (M+0, M+1, M+2, M+3,.) were corrected for natural isotope abundance (Midani
et al., 2017) and the label incorporation or 13C enrichment was calculated based on relative isotopolgue abundance (in %), in each
one of two analyzed conditions (Roci et al., 2016).
Mitochondrial Functional Assays
High resolution respirometry. For measuring mitochondrial respiration in Drosophila brains: ten fly heads from 4 days old male
were rapidly dissected under a microscope and mechanically homogenized in Miro6 Buffer (20 mM HEPES, 110 mM sucrose,
10 mM KH2PO4, 20 mM taurine, 60 mM lactobionic acid, 3 mM MgCl2, 0.5 EGTA, pH 7.1, 1 mg/ml fatty acid free BSA, catalase
280 U/ml) (Krumschnabel et al., 2015), then immediately loaded into an Oroboros 2K oxygraph chamber filled with Miro6 bufferCell 180, 1178–1197.e1–e9, March 19, 2020 e8
equilibrated at 25C. Drosophila bodies. For mitochondrial respiration in fly bodies, fly heads were rapidly removed and bodies were
mechanically permeabilized in Miro6 Buffer. The body homogenates were then spun at 200 g for 5 minutes and the supernatant was
immediately loaded into the Oroboros 2K oxygraph. In each of these protocols, the intactness of the mitochondrial outer membrane
was checked by addition of exogenous cytochrome c. Oxygen consumption rates were measured before and after addition of the
following sequence of substrates and specific inhibitors: 1) 2.5 mM pyruvate, 1 mMmalate in flies (CI leak), followed by 2.5 mM ADP
to determine complex I-driven phosphorylating respiration (CI OXPHOS). 2) 5 mM succinate to determine the phosphorylating
respiration driven by simultaneous activation of complex I and II (CI+II OXPHOS). 3) Titrating concentrations of the mitochondrial
uncoupler CCCP to reach themaximal, uncoupled respiration (CI+II electron transfer system, ETS). 4) 200 nM rotenone to fully inhibit
complex I-driven respiration and measure complex II-driven uncoupled respiration (CII electron transfer system, CII ETS). 5) 0.5 mM
Antimycin A to block mitochondrial respiration at the level of complex III. Residual oxygen consumption was always negligible. 6)
2 mM ascorbate, 0.5 mM TMPD to measure cytochrome c oxidase (CIV or COX)- driven respiration. 7) 300 mM potassium cyanide
to specifically block cytochrome c oxidase activity and measure residual background oxygen consumption caused by chemical
interaction between ascorbate and TMPD. Cytochrome c oxidase-driven respiration is the cyanide sensitive oxygen consumption.
NADH and NADt levels were measured from brain lysates using the NAD/NADH Quantitation Colorimetric Kit (Biovision, K337). The
enzyme activity of IDH was determined from isolated mitochondria using the BioVision kit (K756-100). Mitochondria were isolated as
previously described (Depner et al., 2014; Yoon et al., 2017). Citrate synthase (CS) activity wasmeasured using theMAK193 assay kit
(Sigma-Aldrich). Briefly, isolatedmitochondria from 100 fly brains were used for measuring the CS activity. CS activity was calculated
using a coupled enzyme reaction, which leads to a colorimetric (412 nm) product proportional to the enzymatic activity present. One
unit of CS is the enzyme that generates 1.0 mmole CoA per min at 25C and pH 7.2. The absorbance was measured in a microplate
photometer at 412 nm.
Electron microscopy. Brains from 3-5 days old male flies were dissected in cold PBS 1x and fixed overnight in 2% paraformalde-
hyde and 2.5% gluteraldehyde in 0.1 M sodium cacodylate buffer pH 7.4. After rinsing in 0.1 M cacodylate buffer, the samples were
post fixed in 1:1 2%OsO4 and 0.2Mcacodylate buffer for 1 hour. After 3water washes, samples were dehydrated in a graded ethanol
series and embedded in an epoxy resin (Sigma-Aldrich). Ultrathin sections (60-70 nm) were obtained with an Ultrotome V (LKB) ul-
tramicrotome, counterstained with uranyl acetate and lead citrate and viewed with a Tecnai G2 (FEI) transmission electron micro-
scope operating at 100 kV. Images were captured with a Veleta (Olympus Soft Imaging System) digital camera. Quantification of
mitochondria perimeter and area was performed by using ImageJ software.
ELISA. GABA levels were determined from fly brains using the GABA ELISA Enzyme immunoassay (IBL, ID59301). Briefly, total
brain lysates, isolatedmitochondria and vesicles (Depner et al., 2014; Yoon et al., 2017) were used for GABA derivatization. The sam-
ples were incubated with a polyclonal antibody against GABA-derivative, together with assay reagent containing GABA-derivative
(tracer). The concentration of antibody-bound tracer is inversely proportional to the GABA concentration in the sample. Peroxidase
conjugate was added to detect the tracer and tetramethylbenzidine (TMB) served as a peroxidase substrate. The absorbance was
measured in a microplate photometer at 450nm.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using Graphpad Prism 8. Statistical parameters including the statistical test used, exact value of
n, what n represents, andmeasures of distribution and deviation are reported in the figure legends. Images utilized within figure sche-
matics have been adapted from https://smart.servier.com/. Data are represented as individual data points with the mean and stan-
dard error of the mean (SEM).
DATA AND CODE AVAILABILITY
The data that support the findings of this study and the R scripts analyzing the social space behavior are available from the corre-






















































































































































































































































































































Figure S1. CYFIP Haploinsufficient Flies Have Deficits in Social Behavior and Hyperactivity, Related to Figure 1
(A) Female Cyfip85.1/+ flies show a decreased competition for food. Control (w1118) and Cyfip85.1/+ female flies were analyzed for total number of social in-
teractions in a competition for food assay. n > 12 groups of 8 flies. Data are shown with box and whisker plots where the line inside the box indicates the median,
***p < 0.001, Mann–Whitney test. (B, C) MaleCyfip85.1/+ flies are hyperactive. (B) Locomotion activity of control and Cyfip85.1/+ flies was monitored over 24 hours
and (C) during the morning period ZT0-ZT6. n > 40 flies for each genotype were tested. mean ± SEM, **p < 0.01, ns, not significant, Mann–Whitney test. (D, E) No
negative geotaxis phenotype in Cyfip85.1/+ flies. Negative geotaxis response was measured in 5 days old Cyfip85.1/+ and control male (D) and female (E) flies.
n > 30 flies for each genotype, mean ±SEM. ns, not significant, Mann–Whitney test. (F)CyfipmRNA levels are decreased in adult brains upon pan-neuronal CYFIP
knockdown (29C) in comparison to parental control strains. The levels ofCyfipwere normalized to rpl13mRNA. n = 3 for each genotype, mean ± SEM. *p < 0.05,
Kruskal-Wallis test, Dunn’s multiple comparison test. (G) Acute knockdown of CYFIP in adult male flies is sufficient to produce the phenotype in the competition
for food assay. Adult-specific abrogation of CYFIP (UAS-Cyfip-IR) (29C) pan-neuronally compared with uninduced (18C), transgene-alone and driver-alone
control flies were analyzed for total number of social interactions. Conditional overexpression of CYFIP in the mutant background (genetic rescue, UAS-Cyfip,
Cyfip85.1/+) in comparison with the uninduced transgene (18C) reverses social defects of Cyfip85.1/+ flies. n = 14 independent experiments with 8 flies per
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(legend on next page)
Figure S2. The Proteome of Cyfip85.1/+ Mutant Flies Revealed Maladaptive Mitochondrial Function and an Altered TCA Cycle, Related to
Figure 2
(A) Electron transport chain and (B) TCA cycle modified from WikiPathways (https://www.wikipathways.org/index.php/WikiPathways) for Drosophila mela-



















































































































































































































































Figure S3. Increased Mitochondrial CI Subunit in Cyfip85.1/+ Fly Brains, Related to Figure 3
(A) Mitochondrial membrane potential is increased in Cyfip85.1/+ brains. Left, representative Z projection of confocal images of fly brains from control and
Cyfip85.1/+ stained with Rhodamine 123. Right, quantification of fold change in Rhodamine 123 fluorescence intensity from the antennal lobes (AL) area. n = 11-12
brains per genotype, mean ± SEM, *p = 0.0167, Kruskal-Wallis test, Dunn’s multiple comparison test. (B, C) Upregulation of Complex I subunit NDUFS3 in
Cyfip85.1/+ flies (B) Left panel, representative western blot of protein extracts from fly brains using antibodies to detect the mitochondrial proteins HSP60, ATP5B,
NDUFS3 and TOM20. Right panel, quantification upon normalization to Syntaxin, n = 4 per genotype, mean ± SEM, *p < 0.05. Kruskal-Wallis test, Dunn’s multiple
comparison test. (C) VDAC/Porin level does not change in the Cyfip85.1/+ flies. Left panel, representative western blot of protein extracts from fly brains using an
antibody to detect the mitochondrial marker VDAC/Porin. Right panel, quantification upon normalization to Tubulin, n = 4 per genotype, mean ± SEM, ns, not
significant, Mann–Whitney test. (D) Citrate synthase (CS) activity does not change in theCyfip85.1/+ flies. Measurement of mitochondrial CS activity in control and
Cyfip85.1/+ fly brains. n = 5 per genotype, mean ± SEM, ns, not significant, Mann–Whitney test. (E, F) Feeding is not altered in the Cyfip85.1/+ flies. (E) Food
consumption during the day time. Groups of 5-7-day-old flies were analyzed every 2 hours (ZT0, ZT2, ZT4, ZT6). (F) Quantification of food consumption over 24
hours (see STAR Methods). At the given time points, flies were collected, homogenized, and the absorbance of the supernatant measured at 625 nm (as readout
for the blue dye in the food). mean ± SEM, ns, not significant, Mann–Whitney test.
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Figure S4. Cyfip85.1/+ Flies Have High Levels of Amino Acids that Are TCA Cycle-Related, and Social Deficits Are Restored by Rotenone
Treatment, Related to Figures 4 and 5
(A) Liquid chromatography-mass spectrometry revealed that specific amino acids related to the TCA cycle are higher in Cyfip85.1/+ brains compared to control
flies. Amino acids inCyfip85.1/+ brains normalized to control and mg of protein (n = 5, groups of 10 fly brains), mean ±SEM *p < 0.05, **p < 0.01, Kruskal-Wallis test,
Dunn’s multiple comparison test. (B) Specific chemical reactions of the TCA cycle are affected in the Cyfip85.1/+ brains. Contribution of [U-13C6] glucose to the
TCA-cycle metabolites such as glutamate, glutamine and aspartate inDrosophila brain tissue following 6 hours feeding with [13C] glucose. The x axis denotes the
13C-isotopologue profile (i.e., the mass isotopologue distribution - MID) of labeled metabolites following the incorporation of [13C] glucose skeleton. The
catabolism of 13C labeled glucose leads to M+3 pyruvate. The decarboxylation of pyruvate makes M+2 acetyl-CoA in the mitochondria, which is then incor-
porated intoM+2 citrate. All the TCA cycle intermediates, downstream of citrate, have amass ofM+2. Values shown aremean ± sem (n = 5, 10 brains were pooled
per each sample). *p < 0.05; **p < 0.01, ***p < 0.001, 2way ANOVA, Sidak’s multiple comparisons test. (C) Rotenone treatment does not affect control flies.
Competition for food upon treatment with different concentrations of rotenone in control flies. n R 10 groups of 8 flies, mean ± SEM. (D) The positive effect of
(legend continued on next page)
rotenone treatment is reversible in Cyfip85.1/+ flies. Cyfip mutant flies were treated for 4 days (4d) with 10 mM rotenone and then tested for 5 days of the post-
treatment period in competition for food assay. The comparison was with the control in each case. n > 10 groups of 8 flies for each condition were tested. mean ±
SEM, ****p < 0.0001, **p < 0.01, Kruskal-Wallis test, Dunn’s multiple comparison test. (E) Rotenone does not rescue hyperactivity in Cyfip85.1/+ flies. Locomotion
upon treatment with 10 mM rotenone for 4 days (4d) was analyzed inCyfip85.1/+ flies. Locomotion wasmonitored over 24 hours. n > 40 flies for each conditionwere
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 Control  Cyfip85.1/+
Figure S5. GABA-Dependent Excitability and Number of GABAergic Neurons Are Not Affected in Cyfip85.1/+ Flies, Related to Figure 6
(A) Decreased Cyfip mRNA levels upon CYFIP knockdown in GABAergic neurons (FACS sorted cells) (white bar) in comparison to control flies (black bar). The
levels of Cyfip were normalized to rpl13 mRNA. n = 3 for each genotype, mean ± SEM. **p < 0.01, Mann–Whitney test. (B) Scheme of the GABAergic neuronal
subsets where CYFIP was knocked-down. APL (GABAergic and Octopaminergic) and DPM (GABAergic and Serotonergic). The LN (GABAergic) neurons regulate
the Projection neurons (PN). (C) No changes in presynaptic excitability. Representative false color-coded image showing pre-synaptic Ca2+ influx in GABAergic
(n > 8) and APL (n > 6) neurons upon depolarization (50 mM KCl). The traces indicate the dynamics of Ca2+ influx, quantified as DF/F0 (%) in synaptophysin-G-
CaMP fluorescence over time (t0 indicates KCl delivery). The bar diagram indicates Max DF/F0 (%). mean ± SEM, p > 0.05, Mann-Whitney test. (D-F) No changes
in the number of GABAergic neurons. (D) Left, representative Z projections of confocal images of control andCyfip85.1/+ fly brains stained with nc82 (neuropil) and
(legend continued on next page)
GAD1 antibody. Right, quantification of GAD1 relative fluorescence (n > 11).White box indicates the area of quantification. Scale bar, 100 mm.Mann-Whitney test.
(E) Left, representative western blot of GAD1 levels from control and Cyfip85.1/+ adult head lysates. Left, quantification of relative levels to neuronal marker









































































































































































































































































































































































































































































GABA effect duration 
Figure S6. GABA Supplementation or Aralar Inhibition Restores Social Deficits in Cyfip85.1/+ Flies, Related to Figures 5 and 6.
(A) No changes in glutamate levels as determined by HILIC-MS/MS in control andCyfip85.1/+ brains. n = 5 (group of 10 brains) per genotype, mean ± SEM, Mann-
Whitney test. (B) Subcellular fractionation and enrichment in mitochondria and synaptosomes. Shown is a western blot of the respective fractions. Bruchpilot
(BRP) was used as synaptic marker and ATP5B was used as mitochondrial marker. (C-E) Increasing GABA availability rescues competition for food behavior. (C)
(legend continued on next page)
Competition for food of Cyfip85.1/+ flies upon treatment (2-5 days) with 100 mM DABA, and (D) 1 mM VPA. (E) Conditional abrogation (29C) of CYFIP
pan-neuronally in adults upon GABA treatment for 5 days in comparison with the uninduced (18C) and induced (29C) controls. Flies tested for social in-
teractions. n > 14 independent experiments (group of 8 flies) for each genotype, mean ± SEM, ***p < 0.001, Kruskal Wallis test, Dunn’s multiple comparison test.
(F) Decreased GABA production phenocopies Cyfip mutation. Competition for food upon GAD1 abrogation pan-neuronally in adults. n > 10 independent ex-
periments (each with 8 flies) for each genotype, mean ± SEM, ***p < 0.001, Kruskal-Wallis test, Dunn’s multiple comparison test. (G) Excess of GABA affects
behavior in control flies. Competition for food was monitored upon treatment with 50 mM GABA for 5 days (5d), in control flies. n > 10 independent experiments
(each with 8 flies) for each genotype, mean ± SEM, *p < 0.05, Mann-Whitney test. (H) GABAAR agonist rescues Cyfip mutant behavior. Competition for food of
Cyfip85.1/+ flies upon treatment (1d) with 50 mM Diazepam. (I) Competition for food was rescued upon treatment with VPA, GABA, DABA, in flies with reduced
CYFIP in GABAergic neurons. For all the experiments n > 10 (group of 8 flies), **p < 0.01, ***p < 0.001, ****p < 0.0001, Kruskal-Wallis test, Dunn’s multiple
comparison test. (J) Temporal effect of GABA treatment in competition for food.Cyfip85.1/+ flies were treated for 5 days with GABA (GABA 5d) and then tested for
5 days of the post-treatment period. The comparison was with the control in each case. n > 10 groups of 8 flies for each condition were tested. mean ± SEM,






















































































































































Figure S7. Characterization of Aralar Synthesis in CYFIP Haploinsufficiency, Related to Figure 7
(A) Aralar haploinsufficiency does not rescue hyperactivity deficits of Cyfip mutant flies. Locomotor activity was monitored over 24 hours. n > 40 flies for each
genotype were tested. mean ± SEM, **p < 0.01, ***p < 0.001, Kruskal-Wallis test, Dunn’s multiple comparison test. (B) Aralar inhibition by pyridoxal 50-phosphate
(PLP) restores social deficits in CYFIP haploinsufficient flies. Competition for food of control and Cyfip85.1/+ flies upon treatment (2 days) with 50 mMPLP. n > 10
(groups of 8 flies each), **p < 0.01, *p < 0.05, Mann–Whitney test. (C, D) Aralar expression does not change in the Cyfip85.1/+ flies. (C) Aralar mRNA level was
measured in control and Cyfip85.1/+ fly brains by RT-qPCR and quantified upon normalization to the ribosomal protein L13mRNA. n = 4 (groups of 10 fly brains
each), mean ± SEM, Mann-Whitney test (D) Translational efficiency of AralarmRNA is comparable in control and Cyfip85.1/+ flies. Distribution of AralarmRNA on
polysomes and mRNPs. Bars indicate the percentage Aralar mRNA on polysomes over the total (polysomes + mRNPs). n = 3 groups of 100 fly heads for each
genotype, mean ± SEM, Mann–Whitney test.
